Washington University in St. Louis

Washington University Open Scholarship
All Theses and Dissertations (ETDs)
January 2010

Evaluating the Patient-Centeredness of Medicare Part D
Melissa Hensley
Washington University in St. Louis

Follow this and additional works at: https://openscholarship.wustl.edu/etd

Recommended Citation
Hensley, Melissa, "Evaluating the Patient-Centeredness of Medicare Part D" (2010). All Theses and
Dissertations (ETDs). 148.
https://openscholarship.wustl.edu/etd/148

This Dissertation is brought to you for free and open access by Washington University Open Scholarship. It has
been accepted for inclusion in All Theses and Dissertations (ETDs) by an authorized administrator of Washington
University Open Scholarship. For more information, please contact digital@wumail.wustl.edu.

WASHINGTON UNIVERSITY IN ST. LOUIS
George Warren Brown School of Social Work

Dissertation Examination Committee:
Edward F. Lawlor, Chair
Timothy McBride
Enola K. Proctor
Ramesh Raghavan
Paul T. Shattuck
Bradley Stoner

EVALUATING THE PATIENT-CENTEREDNESS OF MEDICARE PART D

By
Melissa Anne Hensley

A dissertation presented to the
Graduate School of Arts and Sciences
of Washington University in
partial fulfillment of the
requirements for the degree
of Doctor of Philosophy

August 2010
Saint Louis, Missouri

ABSTRACT
The implementation of the Medicare prescription drug benefit (“Part D”) has
brought about many changes in the provision of prescription medications to adults with
serious mental illness. Existing research on the impact of Part D on this population, for
the most part, examines the benefit from the perspective of the physicians who treat these
individuals. This research seeks to use a framework of patient-centered care to examine
the impact of the Part D benefit on adults with mental illness, from the viewpoints of
beneficiaries themselves and the case managers (“community support workers”) who
serve them. In addition, data from the Medicare Web site and the Centers for Medicare
and Medicaid Services are used to examine the patient-centered characteristics of the Part
D program. The Medicare prescription drug benefit is meeting the needs of adults with
serious mental illness, but this is largely because of the assistance that beneficiaries
receive from community professionals. The Medicare Part D program meets some
expectations of a patient-centered program, but there are also definite areas for
improvement, such as involvement of patients and information and education for
beneficiaries.

ii

ACKNOWLEDGEMENTS

The author wishes to acknowledge the financial support of the National Institute
of Mental Health Pre-Doctoral Training Program, the National Institutes of Health PreDoctoral Interdisciplinary Clinical Research Training Program, and the Lilly
Reintegration Scholarship. She would like to thank her dissertation committee,
especially Dean Edward F. Lawlor and Associate Dean Enola K. Proctor, for their
consistent support over many years of effort. In addition, she wishes to acknowledge the
emotional and financial support of her mother, Lila A. Thorpe, without which this project
would not have been possible. The support of David, Janette, Allison, and Benjamin
Hensley has also sustained the author throughout this project.
The care of Dr. Reed E. Simpson, Dr. Susan Englund, Dr. Michael R. Jarvis, Dr.
Charles F. Zorumski, and Dr. Keith E. Isenberg, who never gave up hope that this
achievement was within reach, is deeply appreciated.
This dissertation is dedicated to Dr. J. Harvey Hensley, who is remembered with
much love and appreciation. He is my model for excellence and integrity in teaching and
university service.

iii

Table of Contents

ABSTRACT OF THE DISSERTATION…........................................................................ii
ACKNOWLEDGEMENTS………………………………………………………………iii
TABLE OF CONTENTS………………………………………………………………....iv
TABLES AND FIGURES………………………………………………………………..vi
CHAPTER I: INTRODUCTION…………………………………………………………1
A Profile of Medicare Beneficiaries with Severe Mental Illness………………………....4
Background of Medicare Part D…………………………………………………………..5
Impact of Part D on the Elderly…………………………………………………………...9
Beneficiary Enrollment…………………………………………………………..14
Utilization and Costs……………………………………………………………..14
Cost-Related Medication Non-Adherence…………………………………….…15
Impact of Part D on Individuals with Disabilities……………………………………….15
Questions that Remain…………………………………………………………………...19
CHAPTER II: CONCEPTUAL MODEL: PATIENT-CENTERED CARE…………..22
Introduction………………………………………………………………………………22
Use of the Term “Patient-Centered Care”……………………………………………….22
Patient-Centered Care in Mental Health………………………………………………....29
Empirical Research Using Patient-Centered Care……………………………………….33
Patient-Centered Care as a Dependent Variable…………………………………34
Patient-Centered Care as an Independent Variable……………………………...36
Empirical Research Using Patient-Centered Care: Conclusions……………..…41
Patient-Centered Care as an Evaluation Framework…………………………………….42
Broadening Our Concept of Patient-Centered Care: The Patient-Centered Program…..44
Application of Patient-Centered Care to the Medicare Program………………………...46
Goals of This Research…………………………………………………………………..48
CHAPTER III: OVERVIEW OF RESEARCH DESIGN AND METHODS…………51
Introduction………………………………………………………………………………51
Design……………………………………………………………………………………51
Qualitative Methodology………………………………………………………………...54
Sampling Strategy………………………………………………………………..56
Inclusion Criteria………………………………………………………………...58
Inclusion Criteria for Each Stakeholder Group………………………….59
Data Collection…………………………………………………………………..59
Protection of Human Subjects…………………………………………...59
Focus Groups and Interviews……………………………………………60
Data Entry and Management…………………………………………………….63
iv

Collection of Plan Comparison Data…………………………………………………….64
Plan Comparison Data Sampling Strategy………………………………………66
Variables…………………………………………………………………………67
Methodological Triangulation…………………………………………………………...71
Summary of Research Questions………………………………………………………...72
CHAPTER IV: RESULTS………………………………………………………………73
Introduction………………………………………………………………………………73
Qualitative Data: Sample Description…………………………………………………..74
Consumer Focus Groups…………………………………………………………74
Consumer Demographics……………………………………………………...…74
Community Support Worker Focus Groups……………………………………..76
Community Support Worker Demographics…………………………………….77
Qualitative Results……………………………………………………………………….78
Consumer Results………………………………………………………………..81
Overall Satisfaction………………………………………………………81
Affordability……………………………………………………………..82
Paperwork………………………………………………………………..85
Satisfaction with Generic Medicines…………………………………….87
Pharmacy Interactions……………………………………………………88
Mental Health Agency Interactions……………………………………...90
Community Support Worker Results…………………………………………….91
Managing Beneficiary Problems…………………………………………91
Stress for Beneficiaries…………………………………………………..93
Information and Paperwork Issues………………………………………94
Concerns about Health Care Reform…………………………………….96
Plan Comparison Data: Results…………………………………………………………97
Part D Formularies……………………………………………………………….97
Part D Utilization Management Strategies………………………………………99
Medicare Part D Performance Data…………………………………………….102
Conclusion……………………………………………………………………………...105
CHAPTER V: DISCUSSION AND CONCLUSIONS………………………………108
Introduction……………………………………………………………………………..108
Qualitative Data Analysis: Consumer Codes and Patient-Centeredness……………....108
Consumers’ Assessment of Patient-Centeredness of Medicare Part D………...110
Qualitative Data Analysis: CSW Codes and Patient-Centeredness……………………112
CSWs’ Assessment of Patient-Centeredness of Medicare Part D……………...113
Plan Comparison Data: Discussion…………………………………………………….115
Summary of Findings…………………………………………………………………...120
Conclusions: Is Medicare Part D A Patient-Centered Program?....................................123
Accessibility…………………………………………………………………….123
Care Coordination……………………………………………………………....123
Involvement of the Patient……………………………………………………...124
Information and Education……………………………………………………..124
Secure Transitions……………………………………………………………....125
v

Limitations…………………………………………………………………………..…125
Implications for Social Work Research……………………………………………...…127
Implications for Health Care Policy…………………………………………………....129
Implications for Social Work Policy and Practice……………………………………...130
Implications for Social Work Education……………………………………………….133
BIBLIOGRAPHY…………………………………………………………………….135

Tables and Figures
Table 1.1: Studies of Part D and Older Adults………………………………………….10
Table 2.1: Patient-Centered Care Definitions…………………………………………...26
Table 3.1: Focus Group Questions by Stakeholder Group……………………………...61
Table 3.2: Part D Plan Attributes………………………………………………………..67
Table 4.1: Focus Group and Interview Participants……………………………………..74
Table 4.2: Race/Ethnicity of Consumer Focus Group and Interview Participants……...75
Table 4.3: Educational Level of Consumer Focus Group and Interview Participants…..75
Table 4.4: Summary of CSW Focus Group Participants………………………………..77
Table 4.5: Consumer Data Codes……………………………………………………….79
Table 4.6: Community Support Worker Data Codes……………………………………80
Table 4.7: Formulary Comprehensiveness……………………………………………...98
Table 4.8: Utilization Management Strategies…………………………………………100
Table 4.9: Provision of Information and Help when Members Need It……………….103
Table 4.10: Rate of Complaints about Drug Plan Benefits and Access to Prescription
Drugs……………………………………………………………………………………104
Table 4.11: Rate of Complaints about Joining or Leaving Specific Prescription Drug
Plans…………………………………………………………………………………….105
Table 5.1: Consumer Data Codes and Patient-Centered Care Principles……………..108
Table 5.2: Community Support Worker Data Codes and Patient-Centered Care
Principles………………………………………………………………………………..112

vi

CHAPTER I: INTRODUCTION
The Medicare Prescription Drug, Improvement, and Modernization Act (MMA)
marks the largest change in Medicare policy since its inception in the 1960s (Oliver, Lee
& Lipton, 2004). By introducing a prescription drug benefit (“Part D”) into the Medicare
program, the MMA has substantially changed the way prescription medicines are
financed not only for senior citizens, but also for those living with disabilities (Donohue,
2005). When the Medicare Modernization Act was passed in 2003, there was much
uproar in the health care advocacy community concerning the effect that this new benefit
would have on people with disabilities. Lengthy reports were published and distributed,
predicting turmoil and discontinuities in coverage for many Medicare beneficiaries
(Kaiser Family Foundation, 2004; Medicare Rights Center, 2005; Medicare Rights
Center, 2006). There was concern among health services scholars, as well, about the
impact of Part D implementation on poor and disabled beneficiaries (Donohue, 2005;
Elliott et al., 2005; Avorn, 2006; Simoni-Wastila et al., 2008; Neuman & Cubanski,
2009).
Significant problems were predicted in particular for adults disabled by serious
mental illness. Advocates predicted that the structure of the Medicare prescription drug
benefit would lead to disruptions in coverage and difficulties in obtaining psychotropic
medications, despite regulations specifically mandating coverage of these drugs (MRC,
2006). It was predicted that the switch from one state-administered benefit under
Medicaid to multiple private plans in the Medicare Part D program would confuse many
dually-eligible beneficiaries and complicate access (Perry, Kitchman, & Guyer, 2005;
Avorn, 2006).
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The reality of what has happened since the inception of Medicare Part D is
somewhat different, however (Duggan, Healy & Scott Morton, 2008; Shrank & Polinski,
2009). Research using pharmacy data and Medicare claims information has produced a
mixed picture of the impact of Part D. Part D has, in many cases, resulted in increased
prescription drug utilization and has not substantially increased cost-related nonadherence or created disruptions in coverage (Madden et al., 2008; Basu et al., 2010).
For beneficiaries whose only health care coverage was through Medicare, Part D has
meant assistance with prescription medications for the first time (Levy & Weir, 2009).
Access issues remain, especially for low-income beneficiaries, as illustrated by the
studies conducted by West et al. (2007, 2009) and Huskamp et al. (2009). However, it is
not clear that the switch from Medicaid to Medicare has made these problems worse
(Reschovsky & Felland, 2009).
Surveys of older adult (age 65 and older) beneficiaries indicate high levels of
satisfaction with the program (Healthcare Leadership Council, 2008; Skarupski et al.,
2009). For example, a 2008 survey of older adults found that 86% of beneficiaries stated
that their co-payments were affordable, and 91% said that their Part D plans were a good
value (Healthcare Leadership Council, 2008). The qualitative data that exist show overall
high rates of satisfaction with the Part D benefit, with few beneficiary reports of
problems with access or coverage (Kaiser Family Foundation, 2006; Perry, Dulio &
Cubanski, 2006; Dulio, Perry & Cubanski, 2007; Hargrave et al., 2008). However, very
little of this research focuses specifically on the experiences of adults with serious mental
illness. The papers that do address beneficiaries with serious mental illness do so from
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the viewpoint of psychiatrists (West et al., 2007; Huskamp et al., 2009; West et al.,
2009).
The purpose of this dissertation is to give a voice to Medicare beneficiaries with
serious mental illness and the case managers (community support workers) who serve
them. More knowledge is needed about the impact of Part D on the everyday lives of
people disabled by mental illness. This study will provide first-hand information about
the experiences of Medicare stakeholders with Part D, as well as interpretation of data
provided by the Centers for Medicare and Medicaid Services. The data obtained from
these sources will be examined through the lens of patient-centered care, an important
conceptual framework for 21st century health care. Out of the many questions that arise
in considering the impact of Part D on adults with mental illness, this study will focus on
three in particular. The overall goal of the three questions is to assess the degree to which
Medicare Part D is a patient-centered policy, particularly for adults with mental illness.
These questions will be answered using a mixed-methods approach that incorporates
quantitative data and qualitative inquiry. The questions to be addressed in this study are
as follows:
Research Question 1: How do Part D stakeholders perceive the patient-centeredness
of the Medicare prescription drug program?
Research Question 2: What elements of patient-centered care are recognized by
stakeholders as most critical to an effective prescription drug program?
Research Question 3: How do the “benchmark” plans in one Midwestern state
perform on the measures of patient-centeredness considered most crucial to
stakeholders?
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This chapter will introduce the special concerns of Medicare beneficiaries with
mental illness. It will also provide background on the Medicare prescription drug
program and summarize the research that has been conducted on Part D and older adults,
as well as on Part D and persons with disabilities. The chapter will conclude with a
discussion of questions that have yet to be answered about the experiences of
beneficiaries with mental illness with the Part D benefit, followed by an outline of the
dissertation as a whole.
A Profile of Medicare Beneficiaries with Serious Mental Illness
People with serious mental illness make up a substantial proportion of lowincome Medicare beneficiaries. In 2006, approximately two million of the six and a half
million people who received both Medicare and Medicaid benefits had a serious mental
illness (Donohue, Huskamp, & Zuvekas, 2009). Serious mental illness is defined as a
mental illness, such as schizophrenia or bipolar disorder, which causes disability and
impairs normal functioning (Spaulding, Sullivan, & Poland, 2003). The prevalence of
mental illness is higher among dually-eligible beneficiaries than among other Medicare
recipients (Donohue, 2006), and public funding makes up a large share of spending on
psychiatric medications (Donohue, Huskamp & Zuvekas, 2009). In 2006, Medicare
financed 16 percent of spending for antidepressants, 21 percent of spending for
antipsychotics, and 16 percent of spending for anticonvulsants (Donohue, Huskamp, &
Zuvekas, 2009). Mental illnesses are among the conditions that have driven the increase
in spending on Medicare over the past two decades (Thorpe, Ogden & Galactionova,
2010). Because dually-eligible beneficiaries with serious mental illness are especially
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reliant on public benefits for health care as well as income support, changes in public
policy and program administration can disproportionately affect them (Kennedy & Tuleu,
2007). It can be particularly difficult for beneficiaries with mental illness to navigate
public systems of care (Elliott et al., 2005; Kaiser Family Foundation, 2005). However,
well-administered public programs can also be of tremendous benefit to individuals with
serious mental illness.
Dually-eligible beneficiaries as a whole are more likely to have poor health status
than higher-income beneficiaries. They are also more likely to be members of minority
groups and tend to have less education than higher-income beneficiaries. These
characteristics can create additional vulnerability to program changes, as well as the
potential to benefit from program improvements (Elliott et al., 2005).
Background of Medicare Part D
Prior to 2006, dually-eligible beneficiaries with serious mental illness received
prescription drug benefits through the Medicaid program. In the state of Missouri,
individuals with disabilities with incomes of less than $768 per month are eligible for the
full Missouri HealthNet program, and some individuals with higher incomes are able to
use the MO HealthNet Medically Needy program (Missouri Department of Social
Services, 2010).
Though prescription drug coverage is not a required benefit under Medicaid, all of
the fifty states have chosen to include this benefit as a part of their Medicaid programs.
Before the Medicare Modernization Act, people with serious mental illness who received
SSI benefits or who bought into the Medicaid program through state Medically Needy
(“spend-down”) programs were able to obtain their medications, for psychiatric and
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medical conditions, at a very low cost. For example, in the state of Missouri, copayments for Medicaid-covered prescriptions ranged from fifty cents to two dollars at
most. Some states, such as Missouri, had imposed certain utilization management tools
on their Medicaid prescription drug benefits, in order to prevent antipsychotic polypharmacy and other non-evidence-based prescribing practices (Parks & Surles, 2004).
However, for the most part, people with serious mental illness were able to obtain the
medicines that had been prescribed to them using their Medicaid benefits.
This situation changed with the implementation of Medicare Part D in 2006.
Dually-eligible beneficiaries—those who received Medicare and Medicaid benefits—
were auto-assigned to private Medicare Part D prescription drug plans, and they were no
longer allowed to use their Medicaid benefits for most of their medications (Morden &
Garrison, 2006). Dually-eligible beneficiaries were automatically enrolled in stand-alone
prescription drug plans under Part D if they did not choose a plan for themselves in the
Fall of 2005.

Some beneficiaries (approximately 11 percent in 2008) opted to enroll in

Medicare Advantage (Part C) plans which provided managed-care coverage not only for
prescription drugs but also for services ordinarily covered by Parts A (inpatient) and B
(outpatient; physicians’ services) of Medicare (Neuman & Cubanski, 2009; Donohue,
Huskamp, & Zuvekas, 2009). However, most dually-eligible beneficiaries with mental
illness (89 percent) were enrolled in stand-alone, private prescription drug plans in 2008.
Auto-enrollment was an efficient way to maximize continuity of access for duallyeligible beneficiaries. However, because beneficiaries were randomly assigned to basic
prescription drug plans with low premiums, the plan to which a particular beneficiary was
assigned was not necessarily the best “fit” in terms of formulary or pharmacy network.
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This led to the need for some beneficiaries to switch plans to ensure that their particular
medicines were covered and that they could use their preferred pharmacy.
The Medicare prescription drug program is structured and administered very
differently from state-run Medicaid programs. Although most Medicaid prescription
drug programs are operated through state governments, Medicare prescription drug
benefits are administered through a variety of private insurance company plans, including
stand-alone prescription drug plans and Medicare managed care plans (Bakk, 2009).
Though some protections are in place to ensure that psychotropic medications are
covered by Medicare prescription drug plans, many beneficiaries have a less
comprehensive benefit under the Medicare program than they had under Medicaid
(Kaiser Family Foundation, 2004). Medicare Part D co-payments are often higher than
co-payments under Medicaid, and because of competition among Part D plans, Part D
plans have greater incentives to restrict their formularies or to put utilization management
restrictions in place (Donohue, Huskamp, & Zuvekas, 2009).
For beneficiaries who did not qualify for the low-income subsidy under Medicare
Part D, the “doughnut hole” coverage gap was also a concern. The Medicare Part D
program is structured so that in 2010, Part D plans cover 75% of prescription drug
expenses up to an out-of-pocket spending limit of $2,830 in drug costs. Between $2,830
and $6,440, beneficiaries are responsible for 100% of prescription drug costs. When a
beneficiary’s expenses are greater than $6,440, “catastrophic” coverage takes effect, and
the Part D plan covers 95% of expenses above that amount for the rest of the year (Kaiser
Family Foundation, 2009).
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The low-income subsidy for Medicare Part D fortunately covered the cost of the
Part D premium for basic plans (also called “benchmark” plans). It also covered the
expenses incurred by low-income beneficiaries in the “doughnut hole” coverage gap.
Part D formularies were required by CMS regulations to cover “all or substantially all”
drugs in several classes of medications important to those with severe mental illness, such
as antidepressants and antipsychotics (Huskamp et al., 2007). However, the imprecise
definition of “substantially all” meant that some formularies did not cover certain
medicines needed by beneficiaries, and some important medicines were placed on
restrictive “tiers” of coverage requiring prior authorization (Donohue & Frank, 2007). In
addition, certain classes of drugs, such as benzodiazepines, were forbidden by federal law
from being covered in Part D plans (Yang et al., 2008). Co-payments are also higher
under Part D than under Medicaid; in 2010, co-payments for low-income subsidy
participants were $2.50 per prescription for generic drugs and $6.30 per prescription for
brand-name drugs (Centers for Medicare and Medicaid Services, 2010).
Anecdotal information from mental health providers has suggested that cost and
access problems have resulted from the change in prescription drug benefits, and a recent
survey of psychiatrists suggests that a number of patients have experienced disruptions in
coverage which have, in some cases, led to poor mental health outcomes (West et al.,
2007; Huskamp et al., 2009; West et al., 2009). In addition, the exclusion of
benzodiazepines from coverage under Part D has created problems for some beneficiaries
because disabled Medicare beneficiaries, especially those disabled by serious mental
illness, are more likely to use this class of medicines than older adult beneficiaries (Yang
et al., 2008). Because dually-eligible beneficiaries are more likely to have higher
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prescription drug costs, disruptions in access can cause major health problems (Kennedy
& Tuleu, 2007; Simoni-Wastila et al., 2008; Riley, Levy & Montgomery, 2009).
Information is conflicting, however. Basu, Yin, and Alexander (2010) studied the
impact of Part D on dually-eligible beneficiaries’ medication utilization and did not find
evidence of disruptions in coverage or access problems. Reschovsky and Felland (2009)
reported that access issues existed for non-elderly Medicare beneficiaries, but that the
switch from Medicaid to Medicare does not appear to have made this problem worse. In
contrast, Jacobson and Anderson (2010) reported that coverage and access problems did
occur for dually-eligible beneficiaries during the switch from Medicaid to Medicare.
Donohue, Huskamp, and Zuvekas (2009) examined access to prescription medicines
among dually-eligible Part D beneficiaries with mental illness and found that there were
fewer benchmark plans serving dually-eligible beneficiaries in 2009 than there had been
the year before, and that some incentives existed for prescription drug plans to restrict
access to people with mental illness through use of utilization management tools.
The next section will provide an overview of studies that have examined use of
Part D and Part D-related outcomes among predominantly older adult populations. Three
main themes will be explored.
Impact of Part D on the Elderly
Since 2007, a number of studies, using a variety of sources of data, have explored the
impact of the Medicare Part D program on older adults (defined as adults aged 65 and
over). Three themes that appear frequently in these papers are characteristics of older
adults who enroll in Part D; prescription drug costs and utilization among Part D
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participants; and cost-related non-adherence following the implementation of Part D.
The following table outlines these studies, the questions they asked, and their findings.
Table 1.1 Studies of Part D and Older Adults
Authors

Data Source

Neuman et al.
(2007)

National survey of
older adults

Hsu et al. (2008)

Madden et al.
(2008)

Research Question

Assessing how
many older adults
are enrolled in Part
D; comparing outof-pocket spending
and cost-related
non-adherence
between those with
Part D and those
with other types of
prescription drug
coverage
Survey of older
Assessment of older
adults with
adults’ knowledge
Medicare Advantage of their prescription
coverage in
drug benefits and
Northern California their ways of coping
with drug costs
Medicare Current
Assessment of costBeneficiary Survey
related non(older and disabled
adherence following
adults)
Part D
implementation

Shrank et al. (2008) Pharmacy
dispensing data
related to five
classes of study
drugs: clopidogrel,
proton pump
inhibitors, warfarin,
statins, and
benzodiazepines

Evaluating
medication use, outof-pocket spending,
and medication
switching during the
transition from
Medicaid to
Medicare Part D for
older adult dual
10

Findings
Out-of-pocket
spending and costrelated nonadherence were
greater among Part
D enrollees than
those with VA or
employer-sponsored
coverage.

40% of participants
were aware of the
Part D coverage gap;
15% reported costrelated nonadherence.
There was a small
reduction in costrelated nonadherence among
beneficiaries after
Part D, but those
with the most severe
health problems still
frequently reported
cost-related nonadherence.
Medicare Part D had
no significant effect
on use of any of the
drugs studied. Copayments went
down, except for
benzodiazepines.
Rate of switching
drugs went up for

eligibles
Yin et al. (2008)

Pharmacy claims
data

Zhang et al. (2008)

Pharmacy claims
data

Briesacher et al.
(2009)

Fung et al. (2009)

Joyce et al. (2009)

Levy & Weir

Estimation of
changes in older
adults’ prescription
drug utilization
following Part D
implementation
Assessing effect of
Part D on generic
drug utilization

PPIs but stayed the
same for all others.
A modest increase in
drug utilization and
a small decrease in
out-of-pocket costs
were reported.

From 2005 to 2006,
use of generics grew
more slowly among
Part D beneficiaries
than among those
with other kinds of
coverage.
Pharmacy
Calculation of
81% of nursing
dispensing data
enrollment of
home residents were
nursing home
enrolled in Part D in
residents (older and 2006. The
disabled adults) in
proportion of
Part D; assessment
prescriptions for
of effect of Part D
nursing home
on out-of-pocket
residents paid for
drug spending
out-of-pocket
decreased from 11%
to 8% from 2005 to
2006.
HMO claims data
Calculation of
Prescription drug
impact of coverage
spending and costgap on older adults
related nonwith diabetes
adherence were
enrolled in Medicare higher for those with
Advantage
coverage gap than
for those without a
gap in coverage.
Part D
Assessment of
Cost savings
administrative data
impact of Part D on associated with Part
from CMS
older adults’ out-of- D were concentrated
pocket drug
among low-income
spending and
beneficiaries. Part D
prescription drug
was associated with
use.
decreased out-ofpocket spending and
increased medication
use.
Health & Retirement Estimation of the
Take-up of Part D
11

(2009)

Survey

Pedan et al. (2009)

Pharmacy
dispensing data

Reschovsky &
Felland (2009)

2003 Community
Tracking Study
Household Survey;
2007 Health
Tracking Household
Survey

Safran et al. (2009)

Longitudinal data
from CMS

Schneeweis et al.
(2009)

Pharmacy
dispensing data

Skarupski et al.
(2009)

Cross-sectional data
from Chicago

impact of Medicare
Part D on
prescription drug
coverage among
older adults and
determine predictors
of program
enrollment among
older adults with no
prior drug coverage
Examination of drug
consumption
patterns among
older adults to
determine which
beneficiaries reach
the coverage gap.

was high among
those with no
previous drug
coverage. Demand
for prescription
medicines was the
biggest predictor of
Part D enrollment.

About 1/5 of
beneficiaries reached
the coverage gap but
only a small number
of these reached
catastrophic
coverage levels.
Patients with chronic
conditions reported
the highest drug
consumption.
Exploration of
There was very little
access to
change in older
prescription
adults’ tendency to
medicines following skip filling a
implementation of
prescription
Part D
following Part D
implementation.
Examining changes Those who lacked
in older adults’
drug coverage in
prescription drug
2003 had increased
use and spending as utilization, reduced
a result of Part D
out-of-pocket
spending, and
reduced cost-related
non-adherence
following enrollment
in Part D.
Calculating effect of Part D increased
Part D
utilization, until
implementation on
beneficiaries reached
older adults who
the coverage gap,
had lacked prior
when utilization
drug coverage
decreased.
Examining racial
African-American
differences in Part D older adults enrolled
12

Health and Aging
Project, a
population-based
biracial survey of
older adults

Zhang et al.
(2009a)

Zhang et al.
(2009b)

Zivin et al. (2009a)

enrollment

Medicare Advantage
plan data from a
large insurer in
Pennsylvania

Examination of
whether older
adults’ prescription
drug spending
following Part D
implementation was
associated with
reductions in other
medical spending
Enrollment, benefits, Comparing
and claims data from prescription drug
a large insurer in
usage of older adults
Pennsylvania, from
in an employer
an employer-based
group with no
plan and an
coverage gap with
individual Part D
usage among older
PDP
adult members of a
Part D PDP group
with a coverage gap
or generic coverage
in the gap
Longitudinal survey Calculation of rates
data from the Health of enrollment in
and Retirement
Medicare Part D by
Survey
older adults with
depression and
cognitive
impairment

Zivin et al. (2009b)

Medicare Current
Beneficiary Survey

Calculation of costrelated nonadherence among
beneficiaries with
depression
following
implementation of
Medicare Part D

Basu et al. (2010)

Pharmacy claims

Examination of the
13

in Part D are more
likely to have
chronic health
conditions and low
incomes than White
older adults in Part
D.
There was an
increase in
prescription
utilization but only a
minimal offset of
other medical costs
in the Medicare
Advantage program.
More beneficiaries
reached the
“doughnut hole”
level of spending in
the plan that had no
gap, as compared to
the plan that had a
gap. Those lacking
coverage in the gap
reduced their
spending on
prescription drugs.
Older adults with
depression and
cognitive
impairment were
more likely than
other beneficiaries to
sign up for a Part D
plan.
Cost-related nonadherence did not
decline among
beneficiaries with
depressive
symptoms relative to
those without
depressive
symptoms.
The implementation

Maciejewski et al.
(2010)

data

effect of Part D on
dually-eligible older
adults’ prescription
drug use and
expenditures

Medicare Current
Beneficiary Survey

Examining patient
factors and
medication
acquisition
strategies impacting
enrollment in
prescription drug
plans among
beneficiaries with
no prior drug
coverage.

of Part D had no
effect on duallyeligible
beneficiaries’ use of
prescription
medicines or their
expenditures on
medicines.
Older adults without
prior drug coverage
were more likely to
enroll in Part D if
they were younger
(age 65-74), female,
non-Hispanic white,
or married or
widowed. A greater
number of selfreported medical
conditions was also
associated with
enrollment in Part D.

Beneficiary Enrollment
The literature on characteristics of beneficiaries who enroll in Part D tends to
indicate that more vulnerable groups of beneficiaries were actually more likely to sign up
for Medicare Part D than healthier, higher-income beneficiaries (Levy & Weir, 2009;
Skarupski et al., 2009; Zivin et al., 2009a). Maciejewski et al. (2010) found that
beneficiaries with greater numbers of self-reported health conditions were more likely to
enroll in Medicare Part D than beneficiaries who reported themselves to be healthier.
Utilization and Costs
The evidence on the effect of Part D on utilization and costs is mixed. It seems
that beneficiaries who had no drug coverage prior to Part D tend to experience increased
utilization as well as decreased costs (Yin et al., 2008; Joyce et al., 2009; Safran et al.,
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2009). For dually-eligible beneficiaries, who had Medicaid drug coverage prior to Part
D, implementation of the Medicare drug benefit seems to have had little impact on costs
or utilization (Basu et al., 2010).
Cost-Related Medication Non-Adherence
Cost-related non-adherence also varies according to whether a beneficiary had
coverage prior to Part D. Among those who had no coverage before Part D, cost-related
non-adherence tended to go down following Part D implementation (Madden et al., 2009;
Safran et al., 2009). For beneficiaries with depressive symptoms who enrolled in Part D,
cost-related medication non-adherence stayed about the same (Zivin et al., 2009b).
Beneficiaries who entered the “doughnut hole” coverage gap were more likely to report
non-adherence (Fung et al., 2009; Zhang et al., 2009b).
Overall, older adults expressed satisfaction with the Part D program, and they
reported few problems with access and cost. Cost-related non-adherence went down
among those who had not had prior prescription drug coverage, and it tended to stay the
same for other beneficiaries. There appears to have been some adverse selection of
sicker people into Part D plans. An important question to consider is whether the same
assertions can be made for younger Medicare beneficiaries with disabilities, and whether
their situations might differ substantially from elderly program participants.
Impact of Part D on Individuals with Disabilities
Relatively little attention has been directed toward studying the effects of Part D
on beneficiaries with disabilities. Beneficiaries with disabilities are defined as Medicare
beneficiaries under age 65 who have a diagnosis that prevents them from being able to
maintain employment (Hall, Kurth, & Moore, 2007). Of those studies that have
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examined the impact of Part D on this population, most have looked specifically at
beneficiaries with serious mental illness. Studies of Part D and individuals with
disabilities have rarely surveyed beneficiaries themselves, instead relying on other
informants and sources of information.
Stuart, Simoni-Wastila and Chauncey (2005) used data from the Medicare
Current Beneficiary Survey from 1998-2000 to predict the impact of coverage gaps on
individuals with chronic illness, specifically diabetes, chronic lung disease, and mental
illness. They predicted that beneficiaries who have these chronic conditions but are not
eligible for the low-income subsidy would have a higher-than-average likelihood of
reductions in medication use and drug spending during the “doughnut hole” coverage
gap. Because medication therapy is often very important in managing chronic illness,
Stuart et al. (2005) noted that this sensitivity to costs could have an adverse impact on
patients’ health.
Hall, Kurth, and Moore (2007) found that many younger dually-eligible
beneficiaries with a variety of disabilities had experienced disruptions in coverage as well
as difficulties with the information provided by the Centers for Medicare and Medicaid
Services and their prescription drug plans. The two main problems that Hall et al. found
were difficulties in accessing needed medications and insufficient knowledge of program
rules. Beneficiaries commonly switched plans because they were unable to obtain the
medications that they needed, yet over half of beneficiaries surveyed did not know how
often they were allowed to change Part D plans.
Donohue and Frank (2007) examined the rate of medication switching that was
occurring among dually-eligible beneficiaries with mental illness as a result of formulary
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restrictions in Part D. They found that a relatively small percentage of beneficiaries (2 to
10 percent, depending on the class of drug) had switched medications as a result of
formulary restrictions and utilization controls. Most dually-eligible beneficiaries
experienced continuity of prescribed medication under the Part D benefit.
West, et al. (2007) surveyed almost six thousand psychiatrists in order to assess
the impact of Part D on dually-eligible beneficiaries with mental illness. They found that
a little over half of the psychiatrists reported that at least one patient had experienced a
medication access problem. Among the patients who had had access problems, about
one-quarter had had a “significant adverse clinical event” such as a trip to the emergency
room or an inpatient hospitalization (West et al., 2007, p. 789). A little less than ten
percent of psychiatrists reported that patients had experienced improved medication
access as a result of Part D.
Wilk, et al. (2008) studied the administrative burden of Part D participation on the
psychiatrists of dually-eligible Medicare beneficiaries. They found that in many cases,
psychiatrists spent one hour on prescription drug-related administrative tasks for every
one hour spent in direct client contact. Administrative tasks included facilitating prior
authorizations for the use of certain prescription drugs, as well as other tasks related to
obtaining medicines for dually-eligible patients. This paperwork burden could
discourage psychiatrists from treating dually-eligible patients; it could also have
implications for quality of care delivered to these patients, as psychiatrists are less and
less able to devote sufficient time to face-to-face clinical care.
Huskamp et al.(2009) also surveyed psychiatrists who treated dually-eligible
patients. They found that during the 2006 calendar year, 44% of the patients reported on
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by these psychiatrists had experienced some sort of access problem related to Part D.
Access problems were associated with increased use of the emergency room for
psychiatric treatment, but not with increased inpatient hospitalization.
West et al. (2009), using data provided by psychiatrists treating dually-eligible
patients, also examined access problems among dually-eligible beneficiaries with mental
illness. Their findings were similar to Huskamp et al (2009); 43.3% of dually-eligible
patients for whom data were provided had experienced access problems with prescription
drugs during 2006. Part D plans’ use of utilization management tools, such as step
therapy, prior authorization, and quantity limits, were associated with access problems.
Access problems were associated with an increased risk of adverse events such as
emergency room visits and increases in suicidal behavior.
Yang et al. (2009) examined non-adherence to prescription medicine regimens
among Part D enrollees with diabetes in six states. They looked at data from both older
adult beneficiaries and younger adult beneficiaries with disabilities. Yang et al. found
that beneficiaries who were under age 65, as well as women, black, or Hispanic patients,
were less likely to be adherent to medications for glycemic control and for cardiovascular
complications of diabetes.
Many beneficiaries with disabilities have experienced very little disruption in
their prescription drug benefits as a result of the implementation of Part D (Donohue &
Frank, 2007). However, some disabled beneficiaries, particularly those with mental
illness, have experienced interruptions in coverage as well as cost and access problems
that have resulted in clinically significant problems (West et al., 2007; West et al., 2009;
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Huskamp et al., 2009). In addition, insufficient knowledge of plan rules and guidelines
appears to be a barrier to utilization of benefits (Hall, Kurth, & Moore, 2007).
Questions that Remain
There needs to be a more thorough examination of the impact of Medicare
prescription drug coverage on the lives of people with severe mental illness. We do not
fully understand how Part D has changed the health and health care of individuals with
psychiatric disabilities, particularly those with low incomes. We especially lack an
understanding of how well the Medicare prescription drug benefit is meeting the unique
needs of beneficiaries who have mental illness. As policy-makers focus more and more
on health reforms that are “consumer-directed” and “patient-centered” (Benjamin &
Fennell, 2007), we will need a more in-depth knowledge of the capacity of this new
Medicare benefit to address the financial and other challenges that individuals with
psychiatric disabilities face.
Some of the questions that remain to be answered regarding the impact of Part D
on beneficiaries with mental illness include the following.
What constitutes a true and accurate picture of the effect of the Medicare
prescription drug program on disabled adults with mental illness?
How have Medicare beneficiaries with mental illness made use of this new
program, and what have their experiences been?
What is an appropriate conceptual framework with which to examine these
questions?
What has been the impact of changes in co-payments on beneficiaries’ ability to
obtain the medications they need?
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How have variations in formulary inclusiveness among plans affected
beneficiaries’ continuity of care?
What sources of information do beneficiaries with mental illness rely on to
understand and utilize their Part D benefits?
Who helps beneficiaries with mental illness to negotiate the paperwork and
service systems associated with the Part D benefit?
How good is the “fit” between the attributes of Medicare prescription drug plans
and the specific needs of beneficiaries with mental illness?
To assess the performance of the Medicare Part D program, it is helpful to
consider the needs of beneficiaries as the first priority. Health reform initiatives of the
last ten or fifteen years have frequently emphasized the importance of patient-centered
care—care that is focused on the needs and wishes of the patient, rather than the
convenience of the care provider (Gerteis et al., 1993). This idea is somewhat late in
coming to the mental health sector (Borg et al., 2009; Pincus et al., 2007). Nonetheless,
the notion of patient-centered care is one that can be used to assess the impact of Part D
coverage on people with severe mental illness. This study will use the framework of
patient-centered care, as developed by the Picker Institute, to evaluate how well Medicare
prescription drug coverage is meeting the needs of this very vulnerable group of
beneficiaries. It will examine the impact of the Medicare prescription drug benefit on
adults with mental illness, and attempt to understand what has gone well for these
beneficiaries, as well as what may have gone wrong. It will examine not only whether
beneficiaries are satisfied with the Part D program, but also why.
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This dissertation aims to address in a more comprehensive way some of the
questions surrounding mentally ill beneficiaries’ use of the Part D benefit.
Methodological triangulation—using both qualitative and plan comparison data—is
employed (Speziale & Carpenter, 2005). Qualitative data from two distinct groups of
Medicare stakeholders, both beneficiaries and their community-based case managers, are
examined and analyzed. In addition, plan comparison data from www.medicare.gov and
Medicare Part D Performance Data are considered. The conceptual framework of
patient-centered care is used as a way to organize the questions asked of the data, and as a
way to understand the results obtained.
Chapter 1 has provided an introduction to the Medicare Part D program and an
outline of the study. Chapter 2 offers an explanation of the conceptual model being used
and reviews the patient-centered care literature from a variety of disciplines. Chapter 3 is
an overview of the research design and methods. Chapter 4 describes the results of the
qualitative and plan comparison data. Chapter 5 provides a discussion of the results and
their application to patient-centered care, as well as implications of the findings for
research, policy and practice, and social work education.
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CHAPTER II: CONCEPTUAL MODEL: PATIENT-CENTERED CARE
Introduction
Patient-centered care is a concept that is used in the health services literature to
describe health care that is guided by the needs and values of the patient, rather than the
health care system, organization, or professional (Institute of Medicine, 2001). It has
been used as a framework for evaluation of health care services and for proposing reform
of the health care system. Patient-centered care (also called person-centered, clientcentered, or patient-focused care) has been adopted as an ideal of practice in a number of
health care professions, including medicine, nursing, occupational therapy, and
rehabilitation (Mead & Bower, 2000; Radwin et al., 2009; Sumsion, 2005; Leplege et al.,
2007). This chapter will discuss the origins of the patient-centered care concept and the
use of this idea in health services research and policy, including its use in mental health.
The use of patient-centered care in health research, as a dependent variable and as an
independent variable, will be reviewed. This chapter will also outline the use of patientcentered care as a method for evaluating health care systems and programs and describe
this investigator’s framework for evaluating the patient-centeredness of the Medicare Part
D program.
Use of the Term, “Patient-Centered Care”
“Patient-centered care” is a term that has its origins in conceptual writings from
the 1960s (Balint, 1969; Balint, Ball & Hare, 1969). Enid and Michael Balint,
psychoanalysts from Great Britain, conducted seminars for primary care practitioners
and medical students in which they taught physicians to “examine the whole person”
(Balint, 1969, p. 269) instead of looking only at physical symptoms of illness. The
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original aim of patient-centered care was to integrate psychotherapeutic methods into
medical practice so that psychological causes of illness would be more likely to be
discovered and explored (Balint et al., 1969).
Patient-centered care was introduced as a clinical method for primary care
physicians in the mid-1980s, by several physician-researchers in Canada and South
Africa (McCracken et al., 1983; Levenstein et al., 1986). These physicians believed that
patient-centered medicine was a set of skills that could be taught to family practitioners,
to help them to consider the patient’s experience and definition of illness as well as the
“pathological diagnosis” (Levenstein et al., 1986, p. 24). They believed that to provide
adequate and appropriate primary care services, the practitioner needed to understand the
patient’s emotional needs.
Patient-centered care was introduced to the health services research field in the
late 1980s by the Picker/Commonwealth Program for Patient-Centered Care, now the
Picker Institute (Picker Institute, 2008). The Picker/Commonwealth Program produced a
volume entitled Through the Patient’s Eyes, which proposed reform of health care in the
United States, based on eight principles which they identified as constituting patientcentered care (Gerteis et al., 1993). Those principles are as follows:
1. Respect for the patient’s values, preferences, and expressed needs: This involves
including patients in decision-making processes to ensure that treatments that are
chosen are congruent with the patient’s values and preferences. It means that
patients need to have options available to them that are in line with their values
and preferences. It also involves defining needs according to the patient’s
perspective, rather than the health care provider’s opinion of what the patient
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needs. This principle of patient-centered care also includes sensitivity to a
patient’s cultural values and the impact those values may have on his/her
perceptions of health care processes.
2. Information and education. This means that patients need information about their
diagnosis and prognosis, as well as education about treatment options that are
available. They also need information about how health care organizations and
programs work so that they can use them effectively.
3. Access to care. Patients need to be able to get timely appointments and need to be
able to obtain care in a location that is convenient for them. Access can also
involve affordability of care; patients must be able to pay for their care in order
for it to be accessible.
4. Emotional support to relieve fear and anxiety. Patients need emotional support
from providers to help them address fear and anxiety associated with diagnosis
and treatment of their condition. Emotional support can be just as empowering as
involvement in treatment decisions, according to the Picker Institute (2010).
5. Involvement of family and friends. Patients should be permitted to involve family
and friends in decisions about treatment as well as processes of care.
6. Continuity and secure transitions between health care settings. The process of
being referred or transferred from one source of care to the next should operate
seamlessly, with the patient being able to switch providers or programs free of
interruptions in care.

24

7. Physical comfort. Patients should receive assistance with pain management and
maintaining physical comfort. Physical comfort can also involve assistance with
activities of daily living.
8. Coordination of care. Providers should communicate with each other so that
services operate in a coordinated way. Providers from different disciplines or
offering different services should coordinate their efforts so that patients
experience care in a less confusing, more continuous way.
(Audet, Davis & Schoenbaum, 2006; originally from Gerteis et al., 1993; Picker
Institute, 2010).
From this basic definition of patient-centered care developed in the early 1990s,
many other iterations of the patient-centered care concept have arisen. “Patient-centered
care” has continued to be used both in the health services research literature and in the
government- and privately-sponsored literature on health care quality. Many different
organizations and researchers have promoted patient-centered care as an ideal for which
the health care system should strive.
Unfortunately, there is little agreement about the definition of patient-centered
care. A variety of attributes of quality health care have been labeled as patient-centered,
including respect for patients’ preferences, adequate access to care, patient empowerment
through information and education, offering patients choices among treatments, attractive
physical design of health care settings, and palatable food choices. Hobbs (2009) points
out that this lack of conceptual clarity has made it difficult to conduct meaningful
research on attributes of patient-centered care. Leplege et al. (2007) discuss the fact that
it is difficult to reduce patient-centered care to a single idea because the concept of
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patient-centered care is inherently anti-reductionist. Nonetheless, additional clarity
regarding the use of the term patient-centered care would be helpful to researchers and
policy-makers.
Saha, Beach and Cooper (2008) mention the development of patient-centered care
from a concept used to describe a particular clinical method to a set of characteristics of
health care systems and organizations. This evolution can be seen in the development
and promotion of many different definitions of patient-centeredness, which are outlined
below. The table below provides a summary of some of the major definitions of patientcentered care, including information on the aspect of the health care process described
and the profession addressed by the definition. “Clinical method” refers to interpersonal
processes between providers and patients. “Processes of service provision” includes
communication between provider and patient but includes other aspects of the process of
health care delivery. “Health care organizations” involves organization, system, and
policy processes and their impact on the patient. Application of each definition to system
and organizational issues—clinical definitions as well as those involving processes and
organizations—is discussed.
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Table 2.1 Patient-Centered Care Definitions
Authors or
organizations
promoting
definition
Picker Institute
(Gerteis et al.,
1993)

Aspect of the
health care
process
described
Processes of
service
provision

Profession

Dimensions of the definition

Not specified

Law, Baptiste
& Mills (1995)

Clinical
method

Occupational
therapists

Bechel, Myers
& Smith
(2000)

Processes of
service
provision

Not specified

Mead & Bower
(2000)

Clinical
method

Physicians

Respect for the patient’s values,
preferences, and expressed needs.
Information and education.
Access to care.
Emotional support to relieve fear
and anxiety.
Involvement of family and
friends.
Continuity and secure transition
between health care settings.
Physical comfort.
Coordination of care.
Individual autonomy and choice
Partnership
Therapist and client responsibility
Enablement
Contextual congruence
Accessibility
Respect for diversity
Involving the patient in treatment
decisions
Increasing patient communication
with providers and patient
understanding of what to expect
from treatment plans, recovery,
and aftercare
Involving family members in care
Biopsychosocial perspective
“Patient-as-person”
Sharing power and responsibility
Therapeutic alliance
“Doctor-as-person”

Institute of
Medicine
(2001)

Processes of
service
provision

Not specified

Coordination and integration
Provision of information and
education to patients
Attention to physical comfort
Emotional support
Involvement of family and friends

Little et al.
(2001)

Clinical
method

Physicians

Exploring the experience and
expectations of disease and illness
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Application to
health care
systems and
programs
Access, secure
transition, and
care
coordination
are all
potentially
system
attributes.

Contextual
congruence and
accessibility
are program
characteristics.

Mentions the
importance of
patient
involvement in
decisionmaking

“Patient-asperson” and
power-sharing
dimensions can
be applied to
the structure
and operation
of health care
programs
Care
coordination
and provision
of information
and education
to patients can
be program or
system
characteristics.
Partnership
between

Berry, Seiders
& Wilder
(2003)

Processes of
service
provision

Physicians

Planetree
Alliance
(Frampton,
Gilpin &
Charmel,
2003)

Clinical
method

Inpatient care
teams

Sumsion
(2005)

Clinical
method

Occupational
therapists

Bergeson &
Dean (2006)

Health care
organizations

Physicians

Scholle et al.
(2006)

Health care
organizations

Physicians

International
Alliance of
Patients’
Organizations
(2007)

Clinical
method and
health care
organizations

Not specified

Understanding the whole person
Finding common ground
regarding management
(partnership)
Health promotion
Enhancing the doctor-patient
relationship
Realistic use of time
Availability
Appropriateness
Preference
Timeliness

Healing human interactions
Patient and family education
Involvement of patient’s support
network
Nurturing through food
Addressing spiritual needs of
patients
Human touch
Use of arts in healing
Alternative and integrative
medicine
Innovations in architecture and
design
Provide information to enable
choice
Participate in negotiating goals
Overcome fear

Improving access to and
continuity with clinicians
Increasing patients’ participation
in care
Supporting patient selfmanagement
Establishing more efficient and
reliable mechanisms for
coordinating care
Ease of obtaining information
Swiftness of practitioner response
to patient inquiries
Referral to educational
opportunities
Availability of care management
Respect.
Choice and empowerment.
Patient involvement in health
policy.
Access and support.
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providers and
patients can be
a program- or
system-level
approach to
service
provision.
Mentions the
importance of
restructuring
delivery
systems to
facilitate
patientcentered
access.
Emphasizes
patient
participation in
care decisions.

Mentions
clients’
appreciation of
programs that
respect their
needs.
Addresses
structures of
care provision
and health care
organizations

Addresses
structures of
care provision
and health care
organizations.
Stresses patient
involvement in
health policy.

Leplege et al.
(2007)

Clinical
method

Rehabilitation
professionals

Robert Graham
Center for
Policy Studies
in Family
Medicine and
Primary Care
(2007)

Processes of
service
provision

Physicians

Shaller (2007)

Health care
organizations

Not specified

Saha, Beach &
Cooper (2008)

Clinical
method and
health care
organizations

Not specified

Radwin et al.
(2009)

Clinical
method and
health care
organizations

Nursing

Information.
Addressing the person’s specific
and holistic properties
Addressing the person’s
difficulties in everyday life
The person is an expert;
participation and empowerment
Respecting the person ‘behind’
the impairment or the disease
Personal physician
Physician-directed medical
practice
Whole person orientation
Care is coordinated and/or
integrated
Quality and safety
Enhanced access
Payment reform
Education and shared knowledge
Involvement of family and friends
Collaboration and team
management
Sensitivity to non-medical and
spiritual aspects of care
Respect for patients’ needs and
preferences
Free flow and accessibility of
information
Within healthcare organizations:
Services aligned to meet patient
needs and preferences, e. g.,
1.
Coordinated/integrated/continuous
2. Convenient/easily accessible
3. Attendant to health promotion
and physical comfort.
Within interpersonal interactions:
Provider understands each patient
as a unique human being, e. g.,
1. Uses biopsychosocial
model
2. Views patient as person
3. Shares power and
responsibility
4. Builds effective
relationship
5. Maintains and is able to
convey unconditional
positive regard
6. Is aware of the “doctor as
person”
Responsiveness
Individualization
Coordination
Proficiency
Patient advocacy

29

Emphasizes
participation
and
empowerment.

Discusses
reform of
payment
system; stresses
enhanced
access and
coordinated
care.
Applies
patientcentered care
principles to
health care
organizations.

Stresses access
and service
coordination as
important
system
characteristics.

Patient
advocacy is
included in the
model.

Patient-Centered Care in Mental Health
Patient-centered care has been promoted as a useful approach to the management
of chronic illnesses, because it values patient preferences and stresses the involvement of
patients in decision-making about care. This idea may have utility in the mental health
sector, in particular. Sharfstein and Dickerson (2006) point out that mental illnesses can
be particularly costly over the long-term, not just in terms of health care expenses, but
also in terms of the impact on the patient’s sense of self. Patient-centered care processes
may be helpful in restoring control and self-esteem to individuals with serious mental
illness.
The Institute of Medicine report on improving mental health and substance abuse
care (2006) gives priority to the idea of patient-centeredness as a framework for reform of
the mental health system. Principles such as respect for patients’ values, preferences and
expressed needs; information and education; and emotional support and alleviation of
fear and anxiety; are quite relevant to mental health services. Too often in the past,
activities such as assessment and treatment planning in the mental health sector have
centered on professionals’ perceptions of patient needs rather than on the priorities of the
patient him/herself (Starnino, 2009). A shift to patient-centeredness would serve to
empower patients to make their own choices.
Despite the potential that patient-centeredness holds, and despite the mention of
patient-centeredness in the IOM report, this notion has been used very little in the mental
health literature. The President’s New Freedom Commission on Mental Health (2003)
put forward as one of its goals the idea that mental health care should be “consumer and
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family driven” (p. 27); however, it does not appear that this criterion is being widely-used
to evaluate mental health programs.

There are concepts such as shared decision-making

(Schauer et al., 2007) and certain uses of the terms “empowerment” and “recovery” that
mirror the values of patient-centered care (Salyers & Tsemberis, 2007). Empowerment in
the community mental health field is frequently used to describe treatment-planning
processes that are driven by the client, rather than determined by the mental health
professional (Corrigan, 2003). Similarly, recovery is seen as a process of healing from
mental illness that the person with the illness directs (Starnino, 2009). However, the
actual term patient-centered care is rarely used in the mental health literature (IOM,
2006). Leplege et al. (2007) discuss the fact that the field of psychiatric rehabilitation
embodies many of the ideas involved in patient-centered care, and they note that
psychiatric rehabilitation scholars and practitioners have seemed to avoid the use of the
term patient-centered care even though they are in agreement with many of its main
concepts.
Mechanic (2007), in his editorial on the state of psychiatric services in the United
States, emphasized the importance of patient-centered mental health care, but it appears
that the implementation of patient-centered care principles in mental health is still in its
early stages. Pincus et al. (2007) discuss the fact that the mental health service delivery
system in the United States needs to increase its focus on the needs and preferences of
patients, as well as involvement of family and friends in decision-making processes.
Pincus and his colleagues also mention that the profession of psychiatry needs to let go of
some of its control to allow patients’ ideas about appropriate care to carry more weight.
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The concept of “personalized medicine” has gained increasing popularity in
psychiatry in recent years (de Leon, 2009). Personalized medicine refers primarily to the
tailoring of pharmacological treatments to individual patients using genetic and other
types of biological information (Moller & Rujescu, 2010). Personalized medicine shares
with patient-centered care the notion that communication with patients is of critical
importance to appropriate provision of care. Several writers who describe the use of
personalized medicine in mental health discuss the primacy of effective provider-patient
communications (de Leon, 2009; Koslow, Williams, & Gordon, 2010).
Wills and Holmes-Rovner (2006) also discuss the adoption of patient decisionmaking processes that respect patients’ preferences. Shared decision-making has become
an increasingly common element of innovative mental health programs. In their review
paper, Adams and Drake (2006) discuss the use of shared decision-making in mental
health services and point out the association between adoption of shared decision-making
practices and positive outcomes such as decreased symptom burden and increased
satisfaction with services. Swanson, Bastani, Rubenstein, Meredith, and Ford (2007) also
make the connection between use of shared decision-making in depression care and
increased patient satisfaction. Shared decision-making is a practice that fits well with
several patient-centered care principles, including information, communication, and
education.
The term “person-centered care” has recently become more widely used to
discuss delivery of mental health care that respects patient preferences; Borg et al. (2009)
report on two programs that exemplify what they call “person-centered care”; one of
these is a U. S. program, and the other is a mental health service innovation from Finland.
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Patient-centered care has the potential to reduce stigma in patient-professional
relationships, as well. By increasing the level of information and education that patients
have, patient-centered care promotes empowerment and choice (Picker Institute, 2010).
Program approaches such as teaching skills of independent living and management of
mental health symptoms give mental health clients more control over their services and
can increase self-direction (Starnino, 2009). Use of these principles in service delivery
can not only decrease self-imposed stigma among mental health patients, but it can also
reduce the negative opinions that professionals may have of mental health patients, by
encouraging them to be more honest and respectful (Corrigan, 2003).
Patient-centered care may have utility as a guide to provider-patient interactions
in the mental health sector as well as program- and system-level reforms. Cott (2004)
discusses the importance of “the expertise of the client” (p. 1411) in designing
rehabilitative services. Starnino (2009) further explores “increased emphasis on
mutuality in the client-worker relationship” (p. 827) as an integral part of recoveryoriented service provision. Actions can be taken at all levels of the care process to give
increased voice to patients’ concerns and introduce patients’ perspectives into decisionmaking processes.
Empirical Research Using Patient-Centered Care
Given the volume of commentary related to patient-centered care and the
frequency with which patient-centered care is invoked as an ideal for health care
professionals and systems, there is a surprisingly small amount of empirical research that
uses measures of patient-centered care. There are a few studies that use patient-centered
care as a dependent variable, examining the impact of certain health care practices and
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organizational characteristics on perceptions of patient-centered care. Patient-centered
care has also been used as an independent variable, to assess the effect of patient-centered
care practices on certain kinds of health care outcomes. Both types of research are
important in advancing an understanding of the significance of patient-centered care for
clinical practices and health care organizations.
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Patient-Centered Care as a Dependent Variable
There have been several studies that have examined the factors which contribute
to a perception of patient-centeredness in health care. The methodology used in these
explorations has varied, including survey methods and qualitative interviewing. In
addition, several different sites of care have been examined, including outpatient settings
and acute care.
One of the earliest examinations of factors that contribute to patient-centered care
was the Picker-Commonwealth Survey of Patient-Centered Care (Cleary et al., 1991). In
this survey, adult patients who had recently been discharged from the hospital were
surveyed regarding their perceptions of hospital practices contributing to patientcenteredness. For many of the questions, patients indicated a high level of satisfaction;
for example, few patients reported problems with physical care. However, on questions
related to trust and relationships with physicians and hospital staff, there was more
variation in responses, indicating that hospital staff needed to do more to build trust with
patients.
Another study which used Picker-Commonwealth surveys to examine the quality
of hospital care was Gooding et al. (1999). Patients who had recently left the hospital
were asked questions about the occurrence of various patient-centered practices. A fairly
low percentage of patients reported problems with physical comfort, but a higher
proportion of patients reported problems during their hospitalization with receiving
emotional support and information/education.
Little et al. (2001a) explored patients’ preferences for physicians’ use of the
patient-centeredness outcomes of communication, partnership, and health promotion, as

35

well as patients’ desire for a prescription or a physical examination. They found that
patients expressed a strong desire for physicians to use patient-centered approaches in
their consultations, stronger than their desire to receive a prescription or a physical exam.
The Commonwealth Fund undertook a national survey of primary care and
specialty care physicians in 2003 to assess the extent to which patient-centered care was
practiced by U. S. physicians (Audet, Davis, & Schoenbaum, 2006). Certain patientcentered care practices, such as care delivered by multidisciplinary teams and efforts to
share medical records with patients, were supported broadly by most physicians.
However, other practices, such as using e-mail to communicate with patients and eliciting
systematic feedback from patients, had been less widely adopted.
Smith, Mitchell & Bowler (2007) reviewed studies of asthma education materials
to assess the patient-centeredness of these educational programs. They associated
patient-centeredness with learner-centeredness in the educational context. They found
that most asthma education materials did not meet expectations of patient-centeredness.
Sumsion and Law (2006) conducted a literature review in which they examined
articles concerning client-centered practice in health care. They sought to identify
common elements of the various definitions of client-centered care. They found that
factors which contribute to client-centeredness included listening and communicating,
partnership, hope, and choice. Sumsion and Lencucha (2007), in a qualitative study
interviewing occupational therapists, explored client-centered collaboration in
occupational therapy practice. The occupational therapists who were interviewed
identified several actions and attributes that contribute to client-centeredness: these
include negotiation, advocacy, and partnership.
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The role of certain factors in the delivery of patient-centered education efforts has
also been examined (Zubialde, Eubank & Fink, 2007). Zubialde, Eubank and Fink
described patient-centered education as an outcome of the use of adult learning models,
stressing such characteristics as humanities skills, caring, and self-directed learning skills.
Helitzer et al. (2010) conducted a randomized controlled trial in which patientcentered communication was the outcome variable. They examined the effects of
communication training on primary care providers’ patient-centered communication
skills, and they found that training did significantly increase providers’ abilities in this
area. Furthermore, when the providers’ communication skills were assessed two years
after the training, their increased capacity to provide patient-centered communication had
persisted.
Patient-Centered Care as an Independent Variable
Patient-centered care has also been examined as a health care process leading to
certain kinds of health and patient-satisfaction outcomes. Some studies have shown
significant associations between the adoption of patient-centered care practices and
improved health care outcomes. Other studies are less conclusive.
An early study of patient-centered care as an independent variable was conducted
by Henbest and Stewart (1990), who examined the association of patient-centered care
with improved patient outcomes. They found that the physician’s use of patient-centered
care was associated with the patient’s perception that the doctor understood his or her
concern, and with the perception that his or her concern had been resolved.
In a study of patient-centered care in diabetes management, Kinmonth et al.
(1998) implemented a training program in patient-centered communication for nurses and
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general practitioners working in southern England. They found that patients whose
providers had completed the training were more satisfied with their communication with
their doctors and had greater satisfaction with treatment than the patients in the
comparison group. However, patients whose providers had completed patient-centered
care training had higher body mass indices and higher triglyceride levels. Kinmonth et
al. theorized that these patients’ indicators of physical health had not improved despite
good communication with their physicians because physicians, in their desire to make a
positive connection with their patients, had not been as confrontational as usual in
addressing issues such as diet, exercise, and weight loss. In sharing the implications of
their study, Kinmonth et al. stressed that focusing on patients’ psychological well-being
should not preclude discussion of important health and preventive behaviors with
patients.
Bechel, Myers, and Smith (2000) examined the implementation of patientcentered care in the inpatient setting. They defined patient-centered care using the Picker
Institute dimensions. Using data from 20 acute care hospitals in Michigan, they
determined that patient-centered care was significantly associated with better patient
outcomes in terms of mortality and complications. However, patient-centered care was
also associated with increased costs of providing care. Bechel et al. suggested, however,
that these increased inpatient costs might be compensated for later in the care process, as
more healthy patients required less outpatient follow-up in the community following their
hospitalizations.
Stewart et al. (2000) examined the association of patient-centered communication
in outpatient encounters with health outcomes and patients’ perceptions of their health
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status. They found that adherence to expectations of patient-centered care was associated
with improved health status and increased efficiency in the care encounter. Patients who
felt that they had been treated in a patient-centered manner during the encounter with the
family physician tended to have fewer follow-up tests ordered for them and fewer
referrals to other providers.
Little et al. (2001b) explored the impact of patients’ perceptions of patientcenteredness on their experiences of enablement, satisfaction, and reduction of symptom
burden in primary care consultations. They found that patient-centered practices led to a
greater sense of enablement, satisfaction, and reduction of symptom burden. Use of
patient-centered practices was also associated with a lower rate of referrals.
Mead and Bower (2002) reviewed the literature on patient-centered
communication in primary care consultations and patient satisfaction outcomes. They
found eight studies which evaluated the patient-centeredness of primary care physicians’
communications, and they concluded that the link between patient-centered
communication styles and patient satisfaction was weak. There did not appear to be
much of a relationship between the degree of patient-centeredness in the physician’s
consultation with the patient and the patient’s level of satisfaction with the visit.
Mead, Bower and Hann (2002) conducted a study in which they used the Roter
Interaction Analysis System to assess the degree of patient-centeredness of 173
videotaped general practitioner consultations. The Roter Interaction Analysis System is a
coding scheme for analyzing the empathy and responsiveness in physicians’
communications to patients. They sought to discover whether there was an association
between a patient-centered consulting style and patient satisfaction and enablement.
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They found that patient-centered behaviors on the part of the physician did not predict
satisfaction or patient enablement.
Patient-centered communication with breast cancer survivors was studied by
Mallinger, Griggs & Shields (2004). They examined breast cancer survivors’ experience
with information and education provided by their oncologists, and they found that
patients’ perceptions of patient-centered behavior were strongly associated with
satisfaction with information provided, both about treatment and about cancer
survivorship.
Ciechanowski and Katon (2006) undertook a qualitative exploration of the
patient-provider relationship in diabetes care. In their study, patients with fearful
attachment styles reported that providers’ patient-centered behaviors helped them to trust
the care process more and to participate more fully in the patient-provider encounter.
The Massachusetts Ambulatory Care Experiences Survey (Safran et al., 2006)
sought to examine the contribution of several provider behaviors and organizational
features during primary care encounters to perceptions of patient-centered care. They
found that organizational access and care integration were organizational characteristics
associated with patient-centered care. In addition, provider behaviors such as help
making health behavior changes and communicating trustworthiness were associated
with a perception of patient-centeredness.
Zandbelt et al. (2007) examined the importance of patient-centered
communication by internal medicine physicians. They found that physicians’ patientcentered communication was associated with patients’ active participation in the health
care encounter. Surprisingly, they found that physicians’ inhibiting behavior, which was
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considered not to be patient-centered, was also positively associated with patients’ active
participation in the visit. They hypothesized that inhibiting behavior was the physicians’
response to patients’ increased participation in the visit.
Patient-centered care principles have been associated with a recovery orientation
in the rehabilitation of patients with severe physical disabilities (Stineman, Kurz,
Kelleher & Kennedy, 2008). Stineman et al. (2008) used a technique called Recovery
Preference Exploration to determine the relative significance of a variety of functional
activities to people with severe disabilities. RPE enabled the participants to specify
which activities were most important to them in their rehabilitation. Stineman et al.
concluded that RPE was a patient-centered method for conducting treatment planning and
assessment with people in rehabilitation settings.
In a study of patient-centered nursing practices on a bariatric unit, Wolf et al.
(2008) found no differences in any of the health outcomes measured between patients in
the intervention group and patients in the control group. All patients had good health
outcomes on measures such as post-operative complications, falls, or nosocomial
infections. Provision of patient-centered nursing care also did not create significant
differences in patients’ perceptions of quality of care or patients’ reports of satisfaction
with care received. The authors noted that this may have been because the study was
conducted in a Bariatric Center of Excellence, and the quality of care in the control group
was most likely quite high as a result.
Radwin, Cabral & Wilkes (2009) explored the relationship of several patientcentered nursing interventions—individualization of care, responsiveness, proficiency,
and care coordination—with outcomes for cancer patients. They found that
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individualization of care was associated with three desired health outcomes: authentic
self-representation, optimism, and sense of well-being. The patient-centered nursing
interventions of responsiveness and proficiency were related to subsequent trust in
nurses.
Empirical Research Using Patient-Centered Care: Conclusions
The empirical research on patient-centered care indicates that there is a
connection between patient satisfaction and patient-centered care practices. The link
between patient-centered care and positive health outcomes has been less strongly
established. Patient-centered care appears strongly related to empathetic communication
between providers and patients. In addition, patients seem to value and prefer patientcentered approaches to communication, treatment planning, and care provision, even
when strong links to better outcomes cannot be made. This provides one substantial
argument for continued use and study of patient-centered care practices in both direct
care and programs/policies.
The current observations from research support continued refinement of the
concept of patient-centered care as it is used in health services research. They also
indicate that approaches to health care that focus on patients’ needs and preferences may
have value in ways that cannot yet be adequately measured. Further research using
patient-centered care as a dependent and as an independent variable may reveal new ways
to assess patient-centered care and its impact on health care processes and outcomes. In
examining health care policy such as Medicare Part D, the lessons contributed by the
existing studies emphasize the importance of communication to patient satisfaction, as
well as the role of patient choice in perceptions of empowerment. However, there
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continues to be a need to establish stronger links between patient-centered care practices
and positive outcomes.
Patient-Centered Care as an Evaluation Framework
Despite the somewhat tenuous relationship between patient-centered care
practices and better health care outcomes, patient-centered care is increasingly being used
as a framework for the evaluation of health care services. The constructs comprising
patient-centered care have been used extensively as a way to evaluate aspects of clinical
interventions, such as patient-provider communication, physical comfort of patients, and
coordination of clinical services (Picker Institute, 2008). As discussed above, patientcentered care is also commonly used to describe aspects of direct care that emphasize
patient empowerment and involvement in decision-making, as well as providers’ efforts
to honor patients’ needs, values, and preferences.
Some recent research suggests that adherence to patient-centered care principles,
on both the clinical and system levels, can improve care efficiency and reduce inequities
(Radwin et al., 2009; Little et al., 2001b). Patient-centered care has also been associated
with higher levels of satisfaction and patient trust (Ciechanowski & Katon, 2006;
Zandbelt et al., 2007). The Agency on Healthcare Research and Quality, in their 2009
report on health care quality, connected the use of patient-centered care with a variety of
positive health outcomes, particularly reduction in symptoms of illness (AHRQ, 2009).
Delbanco (1995) has also described the ethical responsibility of providers to listen to
patients and consider their concerns foremost. In a line of reasoning similar to
Delbanco’s assertion, Schauer et al. (2007) have stressed the importance of client-
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centered approaches to the values systems of health care providers and have emphasized
the need to evaluate services on the basis of client-centered care principles.
The Picker Institute (2008) has pioneered the use of patient surveys in health care
settings that not only assess patient satisfaction with services, but also measure the
occurrence of certain health care practices that embody patient-centered care. The Picker
Institute has stressed the importance of measuring specific practice behaviors rather than
simply asking patients whether they are satisfied. Global satisfaction surveys frequently
report highly positive results; however, when patients are asked whether their health care
providers helped them in certain ways, the results are quite different (Picker Institute,
2010).
The Institute of Medicine, in its report, Crossing the Quality Chasm, identified
patient-centered care as an important criterion for evaluating health care (IOM, 2001).
The 2001 IOM report includes patient-centeredness as one of its “six aims for
improvement” in the health care system (IOM, 2001, p. 41). The IOM report places an
especially strong emphasis on individual choice and decision-making as a part of patientcenteredness. In addition, the importance of tailoring care to meet the needs of the
patient, rather than the preferences of the provider, is stressed. The IOM emphasized
patient-centeredness not only in its 2001 Quality Chasm report, but also in its 2006 report
on quality in substance use and mental health care (IOM, 2006).
The International Alliance of Patients’ Organizations has embraced the adoption
of patient-centered health care as one of its goals (IAPO, 2008). IAPO emphasizes the
importance of collaboration between patients and health care providers at all levels.
IAPO is a coalition of health care consumer organizations from around the world,
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representing many different conditions, such as cancer, diabetes, epilepsy, and other
serious health diagnoses. IAPO has promoted the adoption of patient-centered care
principles, including patient involvement in the formulation of health care policy, as a
way to evaluate the success of the health care system (IAPO, 2007).
The Agency for Healthcare Research and Quality (AHRQ) has used patientcentered care for the past five years in its report on the quality of U.S. health care
(AHRQ, 2005-2009). AHRQ has adopted patient-centered care as one of its leading
indicators of health care quality. Patient-centered care has assumed enough importance
in the AHRQ’s definition of quality that patient-centered care data has been given its own
chapter in the National Health Care Quality Report for the past several years (AHRQ,
2006-2009). According to the AHRQ, patient-centered care encompasses a variety of
characteristics. One of these is patients’ experience of care, which primarily centers on
the patient’s ability to communicate effectively with the provider. AHRQ also evaluates
care coordination, integration of information, and continuity of care transitions as
components of its patient-centered care definition (AHRQ, 2009).
Broadening Our Concept of Patient-Centered Care: The Patient-Centered
Program
The idea of patient-centered care has been used mostly as a measure of clinical
care. Some of the aspects of patient-centered care, as described by Gerteis et al. (1993)
and as described by some other patient-centered care definitions, are particularly focused
on transactions between the health care provider and the patient. These include
emotional support and physical comfort, for example. However, there are a number of
attributes of patient-centered care that can be used to evaluate health care programs and
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systems. Some of the definitions of patient-centered care described in Table 2.1 are
especially concerned with the application of patient-centered care to health care
programs, such as Shaller (2007) and Saha et al. (2008). Many of the conceptualizations
of patient-centered care include ideas that are applicable to health care programs. Some
of these ideas are as follows:
•

Accessibility. As a clinical attribute, accessibility largely concerns being able to
see a provider at the time and place that are most convenient to the patient. As a
program attribute, accessibility can include affordability of care, as well as access
to customer service in a timely manner (Gerteis et al., 1993; Berry et al., 2003;
Shaller, 2007).

•

Care coordination. Individual providers play a role in coordinating care, but care
coordination can also be supported by efficient structuring of health care
programs to support communication between providers and smooth “hand-offs”
between services (Graham Center, 2007; Saha et al., 2008).

•

Involvement of the patient. This can include shared-decision making in clinical
situations, and it can also include the provision of a variety of care options and
control given to the patient to make the choice among those options. It can also
mean that patients have a meaningful role in policy-making (Mead & Bower,
2000; Bergeson & Dean, 2006; Radwin et al., 2009).

•

Information and education. In addition to provision of information to patients
about treatment options, information and education can include provision of
information about how health care systems and programs work, so that patients
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can use those programs most effectively and efficiently (Bechel et al., 2000; IOM,
2001).
•

Secure transitions. As with coordination of care, secure transitions can involve
“micro”-level clinical transitions, as well as structuring health care systems so that
patients can move seamlessly from one program to another (Gerteis et al., 1993;
Berry et al., 2003).
The concept of patient-centered care has changed expectations in a number of

health care professions regarding the way that providers should communicate with
patients about their care. This has led to more meaningful informed consent, greater trust
and comfort on the part of patients, and more open communication between providers
and patients (Schauer et al., 2007; Ciechanowski & Katon, 2006). The principles of
patient-centered care can also be applied on a broader scale, to make the provision of
health care in particular programs and systems more humane and centered on the needs
and values of the patient. Even in a large bureaucracy like the Medicare program,
principles of patient-centered care can aid our understanding of how this system can be
improved for the benefit of patients.
Application of Patient-Centered Care to the Medicare Program
Prior research on the Medicare program has examined some of the characteristics
of patient-centered policy as they apply to the Medicare benefit. Researchers have
examined the decision-making of Medicare beneficiaries as they use their values and
preferences to choose specific plans. In addition, the role of Medicare patient
informational and educational materials has been examined. The Access to Benefits
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Coalition (ABC) has examined the impact of “person-centered outreach” approaches
specifically related to Part D enrollment (ABC, 2006).
One application of the notion of patient-centered care to the Medicare program
can be seen in research concerning the decision-making process of health insurance
consumers when it comes to selecting health plans. Much of this literature emphasizes
the importance of cost in beneficiaries’ choice of plans (Scanlon, Chernew, & Lave,
1997). However, there is some evidence to suggest that beneficiaries of public health
insurance programs such as Medicare and Medicaid have somewhat different priorities
than those who are privately insured. In particular, Medicare and Medicaid beneficiaries
are quite concerned with access and convenience associated with their health plans—
factors such as geographical location of plan providers and having a wide choice of plan
providers matter much more to Medicare and Medicaid beneficiaries than they do to
those who hold private insurance policies (Farley Short et al., 2002). In addition, other
research suggests that in a health care environment dominated by managed care
strategies, non-cost factors will become increasingly important in all consumers’ choices
of health insurance products (Scanlon et al., 1997). This suggests that patientcenteredness is most likely a very relevant construct in Medicare beneficiaries’
prioritization of Part D plans. Accessible information about plan choices and provider
locations contributes to patient-centered policy.
Another aspect of Medicare policy in which concerns about patient-centeredness
are very relevant is in the quality of information provided to Medicare beneficiaries.
Harris-Kojetin et al. (2001) and McCormack et al. (2001) examined the impact of
Medicare information materials, such as the Medicare and You booklet and the booklet
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describing the Medicare version of the Consumer Assessment of Health Plans Survey
(CAHPS), on elderly and disabled Medicare beneficiaries’ perceptions of the benefit.
Both of these studies found that beneficiaries valued these materials, and McCormack et
al. (2001) found that having these materials helped beneficiaries to feel more confident in
their health plan choices. These informational materials support patient-centeredness in
the delivery of the Medicare program, although dually-eligible and disabled beneficiaries
did report in some cases that they would have appreciated more information about how
the Medicare and Medicaid programs coordinate benefits (Harris-Kojetin et al., 2001).
As mentioned above, the Access to Benefits Coalition has found that outreach
programs seeking to enroll vulnerable beneficiaries in the Part D low-income subsidy
programs are more efficient and effective when they take a “person-centered” approach.
This includes collaborating with individuals and organizations that are trusted by the
beneficiary, as well as providing one-on-one counseling regarding eligibility and
providing access to enrollment in other needs-based programs for which the beneficiary
may be eligible (ABC, 2006).
Patient-centered care can be a useful conceptual framework for considering the
impact of Medicare prescription drug policy. Accessibility, information and education,
and coordination of care are all relevant to Medicare policy in general, as well as to the
operation of Medicare Part D.
Goals of this Research
This study will use the dimensions of patient-centered policy outlined above as a
framework for evaluating the impact of the Medicare prescription drug benefit on the
lives of an important subgroup of beneficiaries: adults with serious mental illness.
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Information from the Centers for Medicare and Medicaid Services, as well as the lived
experiences of Medicare stakeholders, can provide a window into the workings of
Medicare Part D “through the patient’s eyes” (Gerteis et al., 1993). An assessment of the
degree of patient-centeredness of the Medicare Part D program can contribute to our
understanding of beneficiaries’ experiences with the program and provide direction to
health care reform efforts based on that understanding.
It is important to explore the extent to which the Medicare program is patientcentered because the Medicare program serves some very vulnerable beneficiaries:
senior citizens and people with disabilities. These beneficiaries may not be as wellconnected in the community as non-disabled adults, so it may be harder for them to get
what they need from their health care benefits. Also, seniors and people with disabilities
are likely to have a number of medical and mental health co-morbidities which makes it
particularly important for them to be able to get the drugs they need. They are more
likely to have chronic concerns for which ongoing pharmaceutical treatments are
especially important. Psychiatric issues, in particular, may require careful medical
follow-up and attention to the appropriate pharmaceutical treatment, as Huskamp et al.
(2007) state that psychotropic medications are not as “therapeutically interchangeable” as
medicines for other conditions (p. 308).
Donohue (2006) points out that “The extent to which Medicare beneficiaries benefit
from the new drug benefit will depend on the previous sources of coverage, level of drug
spending, and specific characteristics of the plan they choose” (p. 717). This study will
examine the important “specific characteristics” of these plans and their contribution to
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patient-centeredness, and it will explore their priority among adults with mental illness
and their case managers.
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CHAPTER III: OVERVIEW OF RESEARCH DESIGN AND METHODS
Introduction
This chapter provides a detailed description of the design and procedures used in
this study. The conceptual framework of patient-centered care and its application to
health care programs is reviewed. The overall study design and rationale are outlined.
Qualitative methods are described, including topics to be considered in data collection, as
well as procedures to be followed. The methods used for collecting and evaluating plan
comparison data are provided, along with a description of the procedure for integrating
and triangulating qualitative and plan comparison information. The chapter concludes
with a summary of the research questions.
Conceptual Framework: Patient-Centered Programs
There are five main principles of patient-centered care that can be used on a more
“macro” level—that apply to health care programs. As reviewed earlier, they are
accessibility, care coordination, involvement of the patient, information and education,
and secure transitions. These principles can be used in both qualitative explorations of
stakeholders’ experiences as well as examination of plan performance data. These
principles of patient-centered care form a useful framework for the evaluation of health
care programs such as Medicare Part D because they provide insight into patients’
perspectives on the functioning of the program.
Design
This study sought to determine not only whether Medicare stakeholders were
satisfied with the Part D program, but also reasons why they were or were not satisfied.
In order to accomplish this goal, methodological triangulation was employed (Speziale &
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Carpenter, 2007). Methodological triangulation involves using more than one research
methodology to explore a particular question; for example, employing both a qualitative
research approach and a quantitative approach (Bernard, 2002). The purpose of
triangulation is to increase the validity and reliability of study findings. It is thought that
if qualitative and quantitative methods yield similar answers to a research question, the
results are more trustworthy (Bernard, 2002).
First, the lived experiences of Medicare stakeholders were explored using focus
groups and key informant interviews. Data about stakeholders’ perceptions of the
Medicare prescription drug benefit were gathered, allowing beneficiaries and their
community helpers to speak for themselves. The methodology of phenomenological
analysis was used to collect the focus group and interview data (Padgett, 2008).
Phenomenological analysis emphasizes learning through direct observation and the
description of reality through words rather than numbers (Bernard, 2002). The researcher
is trying to see reality “through another person’s eyes” (Bernard, 2002, p. 23). This
approach was used in an attempt to understand stakeholders’ experiences with and
feelings about Medicare Part D. It also fits well with the patient-centered conceptual
framework of the study, in which health care is examined “through the patient’s eyes”
(Gerteis et al., 1993).
In addition to the qualitative component of this study, plan comparison data from
www.medicare.gov and the Centers for Medicare and Medicaid Services were examined
to compare the degree of patient-centeredness of the various low-income-subsidycovered (also known as “benchmark”) plans available in the St. Louis, Missouri area.
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The findings from different data sources and methods serve to reinforce one another and
give confidence to the study results (Speziale & Carpenter, 2007).
Following the collection of these data, the experiences of Medicare stakeholders
were analyzed according to their relevance to various principles of patient-centered care.
The perspectives of beneficiaries and community helpers were examined to see which
aspects of patient-centered care were most important in their assessment of the Medicare
program, and to evaluate how well the Medicare prescription drug benefit met
expectations of a patient-centered program. The approach of content analysis—
examining focus group transcripts to detect the presence of certain salient themes and
ideas—was used to analyze these results (Bernard, 2002).
Plan comparison data were triangulated with the qualitative data. The principles
of patient-centeredness identified as most critical in the qualitative inquiry were used to
evaluate performance data on the six benchmark plans. Plan comparison data were used
to affirm the lived experiences of Medicare stakeholders (Padgett, 2008), to see whether
benchmark Part D plans possessed the characteristics of patient-centeredness that
stakeholders viewed as most important.
The conceptual framework of patient-centered care (Gerteis et al., 1993) was used
to guide the analysis, but the exploration of the data was not limited to patient-centered
care concepts. A content analysis approach was used, in that the investigator explored
presence of themes related to patient-centered care; however, codes were not imposed
upon the data prior to analysis. The investigator attempted to allow the data to speak for
themselves in the collection, coding, and analysis processes (Speziale & Carpenter,
2007). The investigator familiarized herself with principles of patient-centered care prior
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to data coding, but during the process of data coding and analysis, she let the voices of
the stakeholders guide her.
Qualitative Methodology
In this study, focus groups and key informant interviews were used to obtain
qualitative data from participants. Focus groups are facilitated group discussions,
generally consisting of between four and ten participants. The facilitator asks questions
of the group dealing with a focal topic, and discussion of the topic among group members
is encouraged (Bernard, 2002). Focus groups were chosen as the main method of data
gathering because the investigator wished not only to discover stakeholders’ opinions
about the Medicare prescription drug program, but also to understand the reasons why
they held those opinions. The methodology of focus groups allowed stakeholders to talk
with one another about their perspectives.
Key informant interviews were also used with two Medicare beneficiaries. These
beneficiaries were seen as articulate, well-informed individuals with well-thought-out
opinions on the Medicare Part D program (Bernard, 2002). They were not available to
participate during the scheduled focus groups, but they volunteered their perspectives, so
the investigator chose to interview them separately and include their contributions in the
qualitative data that were gathered.
Qualitative methods have not been used often to examine the Medicare Part D
program. Two focus group studies of the Part D program have been conducted in the
past six years. The first, conducted by researchers affiliated with the Kaiser Family
Foundation (Perry, Kitchman, & Guyer, 2005), was not a study of the Part D program
itself, but rather explored the opinions and perspectives of dually-eligible Medicare
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beneficiaries regarding the impending implementation of the Medicare prescription drug
program. In this study, one focus group was conducted specifically with dually-eligible
beneficiaries who had mental health-related disabilities. The other focus group study of
Medicare Part D was a study of access-related issues related to Part D conducted for the
Medicare Patient Advisory Commission by researchers at University of Chicago and
Georgetown University (Hargrave et al., 2008). This study included focus groups with
beneficiaries, physicians, and pharmacists.
The Kaiser Family Foundation has sponsored two projects conducting qualitative
interviews of Part D stakeholders. The “Voices of Beneficiaries” project (Kaiser Family
Foundation, 2005; Kaiser Family Foundation, 2006; Perry, Dulio & Cubanski, 2006;
Dulio, Perry & Cubanski, 2007) interviewed several dozen Part D beneficiaries, ten of
whom were dually-eligible for Medicare and Medicaid, about their opinions and
experiences related to Part D. They interviewed beneficiaries in Lincoln, Nebraska;
Baltimore, Maryland; Sacramento, California; and Miami, Florida and produced four
qualitative reports detailing the responses of the interview participants. These interviews
were mostly conducted by telephone, though some were in person. The Kaiser
Commission on Medicaid and the Uninsured (Buchsbaum et al., 2007) also sponsored an
interview study of “key informants”: health care and social service providers as well as
community leaders who had experience in working with dually-eligible beneficiaries.
A qualitative approach is particularly useful in examining the Medicare prescription
drug benefit because it goes beyond the story told by pharmacy claims data and
beneficiary surveys to explore experiences and opinions of stakeholders. The objective
pursued in the qualitative component of this study was to give voice to stakeholders—
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particularly those with mental illness and their helpers—regarding their perceptions of
Medicare Part D.
Sampling Strategy
As mentioned above, the qualitative component of this study consisted of a series
of focus groups and key informant interviews conducted with Medicare Part D
stakeholders. The purpose of the qualitative component was to obtain in-depth narrative
information about stakeholders’ perceptions of the degree of patient-centeredness in the
Part D program. Focus groups were used in order to obtain the opinions of a range of
people, to understand the factors that influence these opinions, and to generate new ideas
(Krueger & Casey, 2000). Key informant interviews were used to gather information
from stakeholders who had difficulty making time to attend a focus group. The focus
groups and interviews were used to generate new ideas related to the application of
patient-centered care principles to health care policies. The value of focus groups in
eliciting viewpoints of health care stakeholders, and in reducing the distance between
consumers and policy-makers, has been discussed by Delbanco et al. (2001). Rauktis,
Feidler, and Wood (1998) have discussed the role that focus groups can play in
evaluation of programs for people with mental illness. They discuss the fact that focus
groups can be helpful in obtaining information about reasons why consumers are satisfied
with particular programs (Rauktis et al., 1998). Though focus groups are often used in
marketing and business settings, they have been increasingly utilized in social research
on a variety of topics (Bernard, 2002).
Mental health agencies from which participants were recruited were selected
because they provided in-depth case management services to a population of adults with
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serious mental illness. These agencies also serve a large number of adults with low
incomes, who use both Medicare and Medicaid to obtain their health care. This led to the
ability to conduct an intensive exploration of the phenomenon of Medicare Part D
utilization (Ulin, Robinson, & Tolley, 2005).
To learn the perspectives of Medicare beneficiaries with mental illness, six focus
groups and two key informant interviews were conducted at three community-based
mental health agencies. Two focus groups and one key informant interview were
conducted at Agency A, a non-profit agency in the City of St. Louis that provides
housing, psychosocial rehabilitation, integrated dual-disorders treatment, and assertive
community treatment to adults with severe mental illness. One focus group and the
interview were conducted at the Agency A club house. The other Agency A focus group
was conducted at an assisted-living facility operated by the agency. Two focus groups
were held at the headquarters of Agency B, a non-profit agency in the City of St. Louis
that provides case management, integrated mental health and chemical dependency
treatment, and assertive community treatment. Two focus groups and one key informant
interview were held at Agency C, a non-profit agency in the City of St. Louis that
provides supported employment services, psychosocial rehabilitation, and case
management, as well as other mental health services. The groups and interview at
Agency C were held at the agency’s main headquarters, which houses the agency’s club
house program.
Community support workers’ and nurses’ perspectives were also important to this
project. Community support workers and nurses were recruited through Agency A and
Agency C. One focus group was held at Agency C, and two were held at Agency A.
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One community support worker focus group was held at Agency C’s headquarters. One
community support worker-nurse case manager group was held at Agency A’s assistedliving facility. The other community support worker focus group was held at the
headquarters of Agency A.
Inclusion Criteria
Qualitative data were gathered from two different groups of Medicare
stakeholders. Stratified sampling was used to conduct focus groups of Medicare
beneficiaries with mental illness and of community support workers who serve adults
with mental illness.
First and foremost, it was important to obtain information about beneficiaries’
experiences with the prescription drug benefit. Individuals with mental illness were
recruited for these groups by word-of-mouth and through flyers posted at the agencies.
In addition, at Agency A and Agency C, the investigator gave brief research presentations
to clubhouse members to provide information about the study and encourage clubhouse
participants to sign up for the groups.
Community support workers and nurse-case managers also play an important role
in assisting individuals with mental illness to use Part D (Mishler, 2009). Community
support workers and nurses were recruited for focus groups via word-of-mouth and
through informational flyers distributed at the agencies. At Agency A, two team leaders
volunteered their community support teams to participate in groups. At Agency C,
community support workers and team leaders responded to information made available at
the agency. Although groups were open to both community support workers and to
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nurse-case managers, the groups are referred to as community support worker (CSW)
focus groups, as only one nurse-case manager participated.
Inclusion criteria for each stakeholder group.
To participate in the study, Medicare beneficiaries needed to be clients of the
participating agencies. In addition, they were required to be their own legal guardians,
and they had to be beneficiaries of both the Medicare and Medicaid programs. A brief
assessment of each Medicare beneficiary’s cognitive capacity to complete the interview
was conducted before the focus groups began.
Community support workers and nurse-case managers had to be employed by the
agency hosting the focus group in order to participate. They were also required to be
engaged in a direct practice capacity with adults with mental illness.
Data Collection
Protection of human subjects.
All study procedures related to collection of the qualitative data were reviewed
and approved by the Washington University Human Research Protection Office. The
Institutional Review Board of Agency A also approved the study procedures. The
clinical directors at Agency B and Agency C gave approval for collection of qualitative
data at their agencies. The Washington University Human Research Protection Office
waived written consent for this study because the written consent form would have been
the only document identifying participants by name. Verbal consent was obtained from
all participants at the time that demographic information was collected. In addition, the
investigator conducted a brief assessment of each participant’s cognitive capacity prior to
the start of each focus group and interview. A study information sheet was provided to
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each participant outlining the kinds of information that would have been in a consent
form, and the requirements of study participants were explained to all group members
and interviewees. Refreshments (cereal bars, granola bars, and cookies) were served to
focus group and interview participants. All focus group and interview participants were
offered a $10 gift card to a local grocery store to thank them for their participation.
The digital voice recorder containing focus group and interview recordings, hard
copies of study transcripts, and demographic data sheets were stored in a locked file
cabinet in a locked office at the George Warren Brown School of Social Work.
Focus groups and interviews.
Focus groups and interviews were held in a variety of settings at the participating
agencies. At Agency C, the focus groups and the interview were held in conference
rooms at the agency headquarters. At Agency A’s assisted-living facility, focus groups
were held in the group home office and in the living room of the group home. At Agency
A’s headquarters, the consumer focus group was held in a conference room, the
consumer interview was held in the clubhouse, and the CSW focus group was held in the
community support team office. At Agency B, both consumer focus groups were held in
an agency conference room. Due to resource constraints, the investigator conducted all
focus groups and interviews by herself.
Demographic information on race/ethnicity, gender, educational level, and zip
code of residence was collected. Twenty-nine of the 31 consumer participants provided
all demographic data requested. All fifteen of the CSW/nurse case manager participants
provided all demographic data requested.
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Focus group questions addressed stakeholders’ perceptions of various attributes of
Part D plans, particularly those attributes which are relevant to the Picker Institute
definition of patient-centered care. Examples of focus group questions that were used
include the following.
Table 3.1. Focus Group Questions by Stakeholder Group

Consumer
Transition from
Medicaid to
Medicare Part D

How did your health care
change when you switched
from Medicaid drug
coverage to Medicare?
Respect for
How well does your
patients’ needs
Medicare prescription drug
insurance meet your needs
for prescription medicine?
Availability of
How would you describe
choices
your prescription drug
insurance in terms of the
choices it offers you?
Comprehensiveness How would you describe
of coverage
your prescription drug
insurance in terms of the
coverage that it offers?
(Probes: for example, how
are the copayments? How
are the premiums?)
Sources of
What is your main source
information
of information about your
prescription drug
insurance?
Communication
How does your prescription
with beneficiaries
drug insurance plan
communicate with you?
(Probes: do you receive
written communication,
telephone calls, e-mails?)
Coordination of
benefits
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Community Support Worker/Nurse
Case Manager
How did your work with clients
change when dually-eligible clients
were switched from Medicaid to
Medicare Part D?
How well is the Medicare Part D
program meeting the medication
needs of your clients?

How comprehensive is the
Medicare Part D benefit in covering
the medications needed by your
clients?

What is your main source of
information about Medicare?

How could Medicare Part D plans
communicate more effectively with
their beneficiaries?

How well-coordinated is Medicare
Part D with other health care
programs? (such as Medicare A
and B; Medicaid)

Services and
supports provided
to beneficiaries
Becoming more
patient-centered

What kind of help have you
received in using your
prescription drug
insurance?
How could the Medicare
prescription drug program
be more patient-centered?
How would Medicare drug
coverage change if it
became more patientcentered?

What kind of help do you provide
to your clients in using their
Medicare Part D benefits?
How could the Medicare
prescription drug program be more
patient-centered?
How would Medicare drug
coverage change if it became more
patient-centered?

Focus groups ranged in length from 45 minutes to one hour; key informant
interviews ran from 30 to 45 minutes. The length of each group was somewhat shorter
than the usual length for a focus group; this occurred for a number of reasons. First of
all, groups and interviews with consumers were kept somewhat shorter than usual to
accommodate the energy levels and attention spans of participants with thought disorders
(Rauktis et al., 1998). Focus groups with CSWs were kept short because groups were
held in conjunction with team staff meetings, and the amount of time that these case
managers were willing to allot to a research project was limited. It was determined that it
was better to facilitate a short focus group than not to collect the data at all.
In the process of data collection, the investigator sought to obtain an “insider”
point of view on Medicare (Padgett, 2008). Questions were formulated to go inside of
stakeholders’ experiences and understand the benefit from their viewpoint. Patientcentered care concepts were used as an organizing principle, but narratives of
stakeholders’ experiences were sought in the focus groups and interviews. The
investigator was partially successful in achieving this “insider” perspective. In several of
the focus groups, participants “warmed up” to the investigator after several introductory
questions and assurances of confidentiality. Information shared in the groups tended to
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become more detailed as the groups progressed. Participants were encouraged to share
detailed examples of their own experiences, and many chose to do so. The investigator
observed that she was able to gain a greater insider viewpoint when talking to community
support workers, as these participants knew that the investigator had once worked in a
community mental health setting in a position similar to their own. Community support
workers appeared eager to share “war stories” about the Medicare prescription drug
benefit, whereas beneficiaries for the most part expressed few complaints.
Data Entry and Management
Interviews and focus groups were recorded using a small digital voice recorder.
The digital voice recorder was stored in a locked file cabinet in a locked office at the
George Warren Brown School of Social Work. The investigator transcribed all
interviews and focus groups verbatim. Following the transcription of interviews and
focus groups, all transcripts were entered into the NVivo data management program
(QSR International, 2009). Transcripts were coded using a strategy of phenomenological
analysis (Padgett, 2008). Sorrell and Redmond (1995) have discussed the use of small
group interviews to obtain “pictures” of the lived experiences of participants (p. 1120).
Consumer and CSW transcripts were coded separately to allow each stakeholder group to
speak for itself. Recurrent, salient, words and ideas were identified throughout the
transcripts and coded and sorted accordingly (Morse & Field, 1995). Codes were then
grouped into major themes for each stakeholder group.
Collection of Plan Comparison Data
The sources of data for comparison of the six benchmark Part D plans were the
www.medicare.gov Web site and the Part D performance report card data from the
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Centers for Medicare and Medicaid Services. The www.medicare.gov Web site has been
used in previous research on Medicare Part D formularies; Tseng et al. (2007) used
www.medicare.gov to obtain information about drug coverage variation among Part D
plans. They used the information obtained from the Web site to evaluate the proportion
of Part D plans in California and Hawaii that covered certain commonly-prescribed
medications. They noted that abstracting these data from the Medicare Web site took a
considerable amount of effort but made no comments about advantages or disadvantages
of using the prescription drug plan finder. Davis et al. (2007) also used the Formulary
Finder to obtain information about coverage of medications by different Part D plans;
they used the information to compare the generosity of Part D coverage among various
states. Domino et al. (2008) used the Formulary Finder on the Medicare Web site to
estimate changes in prescription drug costs for non-dually-eligible beneficiaries over the
course of a typical year. They also made mention of the fact that using the Formulary
Finder to abstract data about plan coverage was time-consuming. Joyce et al. (2009) used
the www.medicare.gov Web site to abstract information about formularies and out-ofpocket spending for beneficiaries after their first two years in the program.
Researchers from the Kaiser Family Foundation have also used the prescription
drug plan finder on the Medicare Web site to obtain information on covered medications
and the use of utilization management tools in the formulary coverage of Part D plans
(Hoadley, Hargrave, Cubanski & Neuman, 2008).
Data were abstracted from the Medicare Web site by entering the names of
prescription medicines into the Formulary Finder and obtaining information about the
coverage and use of utilization management by each benchmark plan. This was an
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important exercise not only because it provided data about each plan’s formulary, but
also because it approximated the process that the Centers for Medicare and Medicaid
Services expects Medicare Part D beneficiaries to go through each year when they are
choosing a Part D plan. As noted by several of the other researchers who have used the
Formulary Finder to inform their studies, it is a time-consuming and cumbersome
process.
The Part D performance data are publicly available in an Excel spreadsheet that
can be downloaded from the CMS Web site. The performance data are collected by CMS
during their monitoring activities; they are not reported by Part D plans. Plan ratings are
released each fall by CMS (Lee-Martin, personal communication, 7/27/09). This
Medicare Part D “Report Card,” as it is called, has not been used in Part D published
research. It is used by the Centers for Medicare and Medicaid Services for their
monitoring of Part D plans. Plans that receive low ratings on the performance criteria
may receive follow-up attention from CMS or be required by CMS to improve their
ratings (Lee-Martin, personal communication, 7/27/09). The published research studies
on Medicare Part D tend to use pharmacy claims data (for example, Yin et al., 2008; and
Lichtenberg & Sun, 2007) or to use other national surveys of Medicare beneficiaries,
such as the Medicare Current Beneficiary Survey (Madden et al., 2008). For the
purposes of these studies, claims data and survey data are appropriate because the studies
are examining characteristics of individual Part D beneficiaries and their utilization of
prescription medications. For this study, Medicare Part D performance data are
appropriate because they contain information on beneficiary satisfaction with Part D
plans, on the level of the Part D plans themselves. The Part D performance data contain
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up-to-date, accessible information on a variety of aspects of consumer satisfaction with
Part D plans. Since this study is evaluating plans, the performance data are at the right
level of analysis.
Formulary and utilization management information was abstracted from the
www.medicare.gov Formulary Finder in August, 2009. Plan comparison data from the
Centers for Medicare and Medicaid Services Part D Performance Data were downloaded
from the CMS Web site in July, 2009.
Plan Comparison Data Sampling Strategy
The six benchmark plans in the St. Louis, Missouri area whose premiums were
fully-covered by the low-income subsidy in 2009 will be examined. These are: Aetna
Medicare Rx Essentials, Community CCRx Basic, First Health Part D – Premier,
HealthSpring Prescription Drug Plan – Reg 18, Medco Medicare Prescription Plan –
Value, and Medicare Rx Rewards Standard. These plans were identified using the
www.medicare.gov Plan Finder.
The State of Missouri will be used because Missouri has had a reasonably generous
drug benefit under Medicaid, and because Missouri has a variety of low-income-subsidyeligible Part D plans from which beneficiaries can choose. Missouri is also the site of
this research because of the feasibility of collecting qualitative data on stakeholders in the
St. Louis region.
Variables
Data on the various Part D plans were obtained from the Centers for Medicare and
Medicaid Services and the www.medicare.gov Web site. The purpose of the quantitative
analysis was to examine attributes of Medicare prescription drug plans that contribute to
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patient-centeredness. Plans were compared on five attributes to determine which plans
were more or less patient-centered. Each attribute corresponds with one of the identified
dimensions of patient-centered care. Attributes include formulary inclusiveness,
implementation of utilization management tools, beneficiary perception of plan
information, rate of plan complaints, and rate of complaints about plan switching. A
percentage or rate was calculated for each attribute of each plan.
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Table 3.2. Part D Plan Attributes

Attribute

Formulary
inclusiveness

Dimension of
PatientCenteredness
Respect for
patients’ values,
preferences, and
expressed needs

Implementation of
utilization
management tools

Access to care

Rate of complaints
about the drug plan
benefits and access
to prescription
medications

Coordination and
integration of care

Drug plan’s ability
to provide
information or
help when
members need it

Information,
communication,
and education

Attribute
Definition

Attribute Score

Source of
Information

What percentage
of the drugs in
Huskamp et al.’s
(2007) list of
psychotropic
medications does
the formulary
include?

Percentage of
medications
included in the
formulary

www.medicare.gov

Percentage of
medications that
require utilization
management tools

www.medicare.gov

Rate of plan
complaints per
1,000 beneficiaries

Centers for
Medicare and
Medicaid Services

Percentage of plan
members who
report that their
drug plan has
provided them
with information
or help when they
have needed it

Centers for
Medicare and
Medicaid Services

(15
anticonvulsants; 19
antidepressants; 12
atypical
antipsychotics)
What percentage
of the drugs in the
Huskamp et al. list
require the use of
utilization
management tools
such as prior
authorization,
quantity limits, or
step therapy to be
covered by the
plan?
What is the rate of
complaints about
drug plan benefits
and access to
prescription
medications that
have been lodged
with the Centers
for Medicare and
Medicaid
Services?
What is the
percentage of plan
members who feel
that the drug plan
has provided them
with the
information and
help they have
needed?

69

Rate of complaints
about plan
switching

Continuity and
secure transitions

What is the rate of
complaints lodged
with CMS about
joining or leaving
specific
prescription drug
plans?

Rate of complaints
per 1,000
beneficiaries

Centers for
Medicare and
Medicaid Services

For data on the plan formularies, each drug being considered was entered into the
Formulary Finder on the www.medicare.gov Web site to determine whether it was included
in the plan formulary. The list of prescription drugs that was used was taken from the
Huskamp et al. (2007) article in Psychiatric Services, in which the authors used a list of
commonly-prescribed psychotropic medications to compare the inclusiveness of Part D
formularies. The Huskamp et al. list includes 15 anticonvulsants, 19 antidepressants, and
12 atypical antipsychotics. This list does not include several brand-name and generic
medications that were approved by the Food and Drug Administration after the article was
published. For example, generic risperidone is now available in many Part D plans, but
when the Huskamp et al. article was published, only brand-name Risperdal was available to
consumers. This may lead to percentages of drugs covered by plans that do not include
medicines recently added or taken out of plan formularies. Some plans routinely remove
brand-name preparations from formularies once a generic is approved, so using a list that is
two years old may mean that percentages of drugs covered seem unusually low. Other
plans may continue coverage of all preparations but use quantity limits or other utilization
management tools more extensively with brand-name versions of drugs.
Even so, the Huskamp et al. list comprises a reasonably comprehensive list of
psychotropic medications that are prescribed to individuals with chronic psychiatric
disorders in three major categories: anticonvulsants (used in mood disorders),
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antidepressants, and atypical antipsychotics. Although the rates of covered drugs and
rates of drugs affected by utilization management may be slightly different as a result of
new brand-name preparations and generics entering the market, the overall picture of
drug coverage provided by use of the Huskamp et al. list is fairly realistic and includes
almost all drugs commonly prescribed for persons with serious mental illness.
The use of this list also mirrors a real-life problem that many stakeholders face in
using the formulary finder. Though beneficiaries are restricted in the number of times
that they can change plans, Medicare Part D plans can change their formularies whenever
they choose. Keeping up with the rapid pace of changes in plan formularies is difficult
even for the savviest beneficiary. Beneficiaries may not know which of their medications
are available as generics or may not have the most up-to-date knowledge of new
preparations. This makes it difficult to keep track of the many changes in plan
formularies that can happen within a short period of time.
The Formulary Finder on the Web also provided information on which drugs
required utilization management tools such as prior authorization, step therapy, and
quantity limits. Each drug on the Huskamp et al. (2007) list was entered into the
Formulary Finder, and the information provided about utilization management tools was
recorded into a table. The Formulary Finder provides information about prior
authorization, step therapy, and quantity limits. Prior authorization means that the
beneficiary must receive special permission from their health care provider before he/she
can have a prescription for that particular drug filled. In step therapy, the beneficiary is
required to try a lower-cost alternative medication first, and to show that he/she has failed
to have a therapeutic response to that medication, before he/she is allowed to fill a
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prescription for the more expensive medication. A plan uses quantity limits when it
requires a beneficiary to be limited to a certain quantity of the medication per month,
such as 30 tablets per month for a medication that is taken once a day.
Two different rates of plan complaints were obtained from the Part D performance
data made available by CMS. The first was the rate of plan complaints about drug plan
benefits and access to prescription medicines. The other was the rate of complaints about
joining or leaving different prescription drug plans. Complaints about drug plan benefits
and access to medicines provide information about the patient-centered care attribute of
coordination and integration of care. Complaints about joining and leaving prescription
drug plans give insight into transition and continuity of care among plans. The
percentage of plan beneficiaries who believe they get the information or help they need
from their plan has also been taken from the Part D performance data. This helps to
determine the plans’ adherence to the attribute of information and education for
beneficiaries.
Methodological Triangulation
The qualitative and plan comparison findings were obtained sequentially, and focus
group and interview findings were triangulated with plan comparison information. For
example, qualitative findings related to satisfaction with Part D plans, experiences with
formularies, and perception of information and communication from Part D plans were
compared with the quantitative data related to these same concepts. This approach was
chosen to increase confidence in the results of each method. When two different research
methods, such as a qualitative and a quantitative approach, are used together and the
results compared, and similar findings are uncovered, the validity of the findings
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increases (Bernard, 2002). The investigator examined the plan comparison data for
aspects of patient-centered care that appeared most important to Medicare stakeholders.
Performance of benchmark Part D plans was assessed using attributes of patient-centered
care. This helped the investigator to determine whether Part D plans were adhering to
patient-centered care characteristics that mattered most to stakeholders. In the
interpretation of the data, findings were merged so that a unified outcome could be
achieved (Speziale & Carpenter, 2007).
Summary of Research Questions
Through collection of qualitative and plan comparison data, this study sought to
answer three research questions.
Research Question 1: How do Part D stakeholders assess the patient-centeredness of the
Medicare prescription drug benefit?
Research Question 2: What elements of patient-centered care are recognized by
stakeholders as most critical to an effective prescription drug program?
Research Question 3: How do the “benchmark” plans in one Midwestern state perform on
measures of patient-centeredness considered most crucial to stakeholders?
Focus groups and interviews were conducted to determine the attitudes and
experiences of Medicare stakeholders regarding the Part D benefit. The qualitative data
collection also enabled the author to consider the elements of patient-centered care that
stakeholders viewed as most important, and how these elements related to their
experiences of the Part D program. By examining plan comparison data, the author was
able to take these patient-centered care attributes and apply them to the performance of
the six benchmark Part D plans in Missouri in 2009. Assessment of benchmark plans
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relative to the most important patient-centered care attributes gave further insight into the
adequacy of the Part D program in meeting the needs of beneficiaries with mental illness.
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CHAPTER IV: RESULTS
Introduction
In this chapter, results of the qualitative data collection and the quantitative plan
comparison data collection are described. For the qualitative data, the results from the
focus groups and key informant interviews serve to answer the first two research
questions: Research Question 1: How do Part D stakeholders assess the patientcenteredness of the Medicare prescription drug benefit? and Research Question 2: What
elements of patient-centered care are recognized by stakeholders as most critical to an
effective prescription drug program? These results are organized by first describing the
sample, both mental health consumers and community support workers/case managers.
Following this, the analytic process is described, and codes for both consumer and
community support worker (CSW) data are outlined. Major themes of consumer and
CSW data are put forth, along with illustrative quotations from the qualitative data.
Following the presentation of the qualitative findings, quantitative plan
comparison data are discussed. These data answer Research Question 3: How do the
“benchmark” plans in one Midwestern state perform on the measures of patientcenteredness considered most crucial to stakeholders? The sources of the plan
comparison data are described, and the variables to be considered are outlined. This is
followed by a description of the questions answered by each variable explored.
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Qualitative Data: Sample Description
Consumer Focus Groups
There were 29 participants in six consumer focus groups and two participants in
key informant interviews that took place over a ten-week period in Fall, 2009. The
breakdown of participants in each focus group was as follows:
Table 4.1 Focus Group and Interview Participants
Group/Interview
Agency A Group #1
9/15/09
Agency A
Interview #1
9/16/09
Agency A Group #2
11/19/09
Agency B Group #1
9/9/09
Agency B Group #2
9/16/09
Agency C Group #1
8/31/09
Agency C
Interview #1
9/3/09
Agency C Group #2
9/8/09

Participants
3
1

10
2
4
2
1

8

Consumer Demographics
Demographic characteristics were collected on consumer participants.
Participants tended to be middle-aged and older; the youngest participant was 28 and the
oldest was 74. The mean age for consumer focus group/interview participants was 51.5.
Seventeen (54.8%) of the consumer participants were female, and 14 (45.2%) were male.
All 31 consumer participants reported their race/ethnicity. Nineteen participants
(61.3%) were African American. Eight participants (25.8%) were Caucasian; one (3.2%)
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was Asian American. Two (6.5%) reported their race/ethnicity as “American,” and one
(3.2%) was American Indian.
Table 4.2 Race/Ethnicity of Consumer Focus Group and Interview Participants
Race/Ethnicity

Number

Percentage

African American

19

61.3%

Caucasian

8

25.8%

Asian American

1

3.2%

“American”

2

6.5%

American Indian

1

3.2%

Total

31

100%

Twenty-nine participants reported their educational level. Over half of the
participants had a high school education or less; eight (27.6%) had less than a high school
education, and eight (27.6%) were high school or GED graduates. Ten participants had
taken some college courses (34.5%), two (6.9%) were college graduates, and one (3.4%)
had a master’s degree.
Table 4.3 Educational Level of Consumer Focus Group and Interview Participants
Educational Level

Number

Percentage

Less than high school

8

27.6%

High school/GED

8

27.6%

Some college

10

34.5%

College graduate

2

6.9%

Master’s degree

1

3.4%
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Missing

2

6.9%

Total

31

100%

Twenty-nine consumer participants reported their zip code of residence.
Consumer participants came from ten different zip code areas, mostly in St. Louis City.
Three participants reported that they lived in St. Louis County. Fourteen of the
participants (49.3%) came from 63110 or 63108, which are zip code areas very close to
the locations of the community mental health agencies where they were receiving
services. Both of these zip code areas contain high percentages of individuals living
below the poverty line. In zip code area 63110, 22.2% of residents are living below the
poverty line, and 9.6% of residents are living below 50% of the poverty line (“63110 Zip
Code Profile,” 2010). In zip code area 63108, 29.4% of residents are living below the
poverty line, and 14.2% of residents are living below 50% of the poverty line (“63108
Zip Code Profile,” 2010). This is in comparison to an overall poverty rate in the city of
St. Louis of 24.6% in the year 2000 (City of St. Louis CDA, 2005). These numbers are
considerably higher than the averages for the entire state of Missouri, which has 13.4% of
residents living in poverty and 5.5% of residents living below 50% of the poverty line
(“63108 Zip Code Profile,” 2010).
Community Support Worker Focus Groups
Three focus groups were conducted with community support workers over a
three-month period in 2009-2010. Participants were as follows:
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Table 4.4 Summary of CSW Focus Group Participants
Group

Participants

Agency A Community Support Team
1/16/10
Agency A Assisted Living Facility Team
1/16/10
Agency C Community Support Workers
10/28/09

5
4
6

One focus group was conducted at Agency C, with community support workers
and team leaders. One focus group was conducted at Agency A’s assisted-living facility,
with a team leader, two community support workers, and one nurse-case manager. The
last focus group was held at Agency A, with a team leader and community support
workers.
Community Support Worker Demographics
In terms of ethnicity, ten community support worker participants were Caucasian,
three were African-American, one was Asian, and one, who had emigrated from
Germany to the United States, identified herself as “German.” Ten community support
workers were female, and five were male. The average age of community support
workers was 39.5, with the oldest being 66 and the youngest being 26. Six of the CSW
participants reported their residence as being in the City of St. Louis, while nine reported
living in suburban areas.
Ten of the CSW participants had master’s degrees, and five had a college
education. Nine of the participants did not specify the discipline of their degree. Three
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stated that they had degrees in social work; two had graduate degrees in psychology; and
one had a bachelor’s degree in nursing.
Qualitative Results
Focus group transcripts were analyzed using phenomenological analysis (Padgett,
2008). The goal was to identify themes that would provide insight into stakeholders’
experiences with the Medicare prescription drug program. Denzin and Lincoln (2005)
discuss the use of focus groups and other qualitative approaches in an applied manner,
with the goal of informing public policy and professional practice. The intent was to use
the lived experiences of Medicare stakeholders to provide information about the
operation of the Medicare prescription drug program in the lives of a very vulnerable
group of beneficiaries. The juxtaposition of a phenomenological approach with the use
of patient-centered care themes has benefits and drawbacks. Exploring the personal
experiences of stakeholders provided rich, detailed knowledge of the workings of the
Medicare benefit. Using patient-centered care themes to structure these observations
gave immediate practical relevance to the findings and aided in understanding the
meaning of stakeholders’ experiences. However, by using these constructs to shape
observations regarding the data, other themes and experiences may not have been
considered. The investigator attempted throughout the data collection and analysis
process to hear the voices of stakeholders as they discussed their perceptions of
satisfaction and areas of concern related to Medicare Part D.
A content analysis of the focus group data, looking for particularly relevant
constructs and themes, was employed (Morse & Field, 1995). Focus group and interview
transcripts were entered into NVivo (QSR International. 2009) for coding and analysis.
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The transcripts were examined line-by-line for recurring themes and important concepts
related to the lived experience of Medicare stakeholders. Community support worker and
Medicare beneficiary focus groups were coded separately. However, many codes
revealed similar themes across stakeholder groups.

For Medicare consumer data,

nineteen codes were identified. They are as follows:
Table 4.5 Consumer Data Codes
Data Code
Concerns about health care reform
Co-payments okay
Co-payments not okay
Costs okay
Costs not okay
Dental insurance problems (this relates to a
Medicaid cut; it does not relate directly to Medicare
Part D but it is on the minds of many consumers)
Formulary problems
Generic drugs okay
Generic drugs not okay
Help from mental health agencies
Help from pharmacists
Information from Medicare helpful
Information from Medicare not helpful
Medicaid spend-down (again, not directly related to
Medicare Part D but on the minds of many
consumers)
Not satisfied with Part D (General comments
related to dissatisfaction with Part D)
Satisfied with Part D
Paperwork
Problems with Medicare Advantage
Problems with utilization management (in Part D
plans)

All codes related to consumers’ experience with Medicare prescription drug
benefits, except for “dental insurance problems” and “Medicaid spend-down.” Data
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concerning these two codes were identified and coded because these two issues were on
the minds of many Medicare consumers and in some cases affected consumers’
perceptions of the utility and affordability of the Medicare program.
The analysis attempted to strike a balance between a search for themes that have
already proven relevant in other studies of patient-centered care and Medicare and
openness to new topics and ideas expressed by focus group participants. The investigator
accomplished this by reviewing the patient-centered care literature prior to coding the
data, but allowing the coding process to be shaped by themes brought up by participants.
Specific patient-centered care principles were mapped onto data codes after the coding
process was completed, so that themes would not be limited to principles of patientcentered care.
Data from the CSW focus group transcripts were coded and sorted in a process
similar to that used for the consumer data. There was no particular effort made to create
codes that were similar to the consumer codes. However, many of the codes share
characteristics with consumer codes. Fourteen codes were developed for the CSW data.
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Table 4.6 Community Support Worker Data Codes
CSW Data Code
Action on Behalf of Consumer
Communication with Members
Costs Not Okay
Costs Okay
Dealing with Bureaucracy
Health Care Reform
Part D Okay
Pharmacies Helpful
Prescription Issues
Problems with Medicare Advantage
Problems with Physicians
Problems with Switching Plans
Stress for Consumers
Utilization Management

Consumer Results
Consumer data codes have been summarized below in six main categories that
appear consistently throughout the coding. Categories were chosen as significant based
on the frequency with which that particular theme appeared in the transcripts. Categories
are as follows: Overall satisfaction, affordability, paperwork, satisfaction with generic
medications, interactions with pharmacists, and interactions with mental health agencies.
Overall satisfaction.
Overall satisfaction with the Medicare prescription drug benefit was high among
beneficiaries. Many interview participants stated, “I don’t have no problems with
Medicare.” For example, one participant stated, “So, uh, the Part D…I have (Part D
plan) now, and I’m really satisfied with them.” Another participant mentioned, “I don’t
have no problems. I’m very happy for me.”

Another beneficiary commented, “I guess

I’m basically satisfied. Because, I’m thinking it might be just the medication, I take
medication for mental health, you know, depression, anxiety, stuff like that, and then I
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take the medications for blood pressure, and I guess I could be on more medication, if I
didn’t try to take care of myself, you know, I could be on heart medications and stuff like
that.”
Some participants then went on to describe the processes by which they were able
to obtain their medicines, which frequently involved help from a community support
worker (CSW), nurse, or pharmacist. One participant mentioned, regarding her plan
paperwork, “And, like if I need to go to the offices over any of that stuff, she (community
support worker) will let me know, and if she’s available, she’ll go down there with me; if
she ain’t, she’ll instruct me where to go and stuff like that.”
Beneficiaries themselves did not seem to make the connection that they had few
problems because they were receiving a great deal of help, but the help they received was
frequently mentioned after they stated that they had few or no problems. As one
beneficiary commented, “So really, it’s kind of a blessing to have this, because I used to
live on the street, and everything like that, until I got on the medicine and got involved
with this place (community mental health agency).”
“Having no problems” with Medicare equated with being able to get one’s
medicines easily and at a low cost, which most beneficiaries were able to do. An
interviewee offered the following comment regarding Part D satisfaction: “Well, I get
every medication that I need, everything that I’m prescribed by my doctor, by my doctor
here (at the mental health agency), or my doctor at my medical doctor’s office, every
prescription they prescribe, I just take it to the same place, and they fill it. It’s no
problem.”
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Several beneficiaries commented that they could not think of any way that the
Medicare prescription drug program could be made any better. For example, “Now, I
don’t know, but I don’t think, like personally, they can’t do nothing to make an
improvement to it, because my needs are being met.”
Affordability.
The phrase “I don’t have no problems” came up frequently in discussions of cost,
as well. Affordability of medications was the biggest factor influencing access,
according to these beneficiaries. If the co-payment was low, then the medication was
accessible. Most people did seem to think that their medications were affordable under
Part D. In fact, many consumers stated that they had very low co-payments, or that they
did not pay co-payments at all at the pharmacy they used. One consumer said, “…I don’t
have no problem; I just call them (prescriptions) in and…go pick them up, and they’re
ready. I don’t have to pay for them. Everything’s covered.” Low cost-sharing was of
great benefit to these participants. As another beneficiary mentioned, “Both (mental
health agency) and (independent pharmacy) absorb my co-pay, of three dollars or two
dollars or whatever it is, because it’s so low, you know.”
All beneficiaries in the sample were dually-eligible for Medicare and Medicaid.
However, perceptions of affordability were affected by the type of Medicaid coverage in
which the beneficiary was enrolled. Most beneficiaries in the sample had incomes that
were low enough that they received full Medicaid coverage with no premium
requirement. A few of the beneficiaries had somewhat higher incomes and participated
in the Missouri HealthNet (formerly Medicaid) Medically Needy program, or “Medicaid
Spend-Down.” Medicaid spend-down (Medically Needy) is a program under the
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Missouri HealthNet program under which individuals whose incomes are above the
maximum for full MO HealthNet coverage can “spend down” their income each month to
become eligible for MO HealthNet coverage. These beneficiaries must incur and pay for
a certain dollar amount of medical expenses each month to activate their Medicaid
coverage. This dollar amount, the “spend-down,” is seen as a sort of premium for the
Medicaid program. Beneficiaries in this category may or may not be eligible for full
“extra help” under Medicare Part D.
People whose prescriptions were entirely paid for tended to be individuals with
full Medicaid coverage—known by beneficiaries as “straight” Medicaid. Not only did
these individuals have the full “extra help” subsidy under Medicare Part D, but several
local pharmacies also waived their co-payments. For example, “Uh, I have a co-pay, like
maybe a dollar-fifty. Because I got a deal with Medicare Part D. And they don’t pay all
of it. But (independent pharmacy), (mental health agency), absorbs my dollar-fifty.”
Higher co-payments, or premiums for prescription drug insurance, made it harder
to access medications. People who were enrolled in the Missouri HealthNet Medically
Needy program—referred to as Medicaid spend-down, whose incomes were a little bit
higher than those of people on “straight” Medicaid, were more likely to report problems
with co-payments or premiums, even though the Medicare program itself does not have a
spend-down. People in this situation frequently felt that their co-payments and premiums
under Medicare were more than they could afford. In addition, because their medications
were being paid for under Medicare Part D, their expenses for prescription medicines no
longer applied toward meeting their “spend-down,” so their eligibility for the Medically
Needy program was sometimes affected.
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Problems with Medicaid coverage affected perceptions of affordability. Problems
with Medicaid spend-down tended to impact people’s perceptions of the entire system.
Even though consumers with Medicaid spend-down could still get their prescription
drugs through Medicare, the existence of the spend-down frequently confused and
embittered consumers. Several consumers also expressed bitterness over the lack of
dental coverage for adults under the Missouri HealthNet (Medicaid) program. Even
though these issues do not directly affect Medicare coverage, they influenced consumers’
perceptions of health care access and affordability.
One issue that did affect affordability was the use of utilization management tools
by prescription drug insurance plans. A few beneficiaries mentioned that they were not
able to obtain the number of pills prescribed by their doctor for a month. One woman
was taking Effexor twice a day, but her Part D plan would allow her to purchase only 30
capsules a month. She stated that she had to obtain samples or pay cash for the remaining
capsules to get the medicine she needed. Several other beneficiaries mentioned similar
situations, not only with psychotropics but with blood pressure medicines and other
medications. They reported running out of medication in mid-month and not being able
to obtain any more pills. One beneficiary commented, “For your psychotropic
medications, for certain medications, the pharmacy gives you exactly thirty days. But
your appointment for the doctor isn’t exactly thirty days. So what do you do in between,
then?”
Only a few beneficiaries had encountered formulary problems that affected cost
and access. Beneficiaries were concerned about formulary restrictiveness even if they
had not experienced this problem personally, however.
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Paperwork.
Participants were split down the middle in terms of their opinions regarding
information from Medicare and their Part D plans. About half of beneficiaries reported
that this information was helpful and that they were able to get the information they
needed from the materials sent by their plans and by the Medicare program. The other
half indicated that the information they received from their Part D plans and from
Medicare was confusing, not helpful, and much too voluminous to be useful to them.
One typical phrase was, “It’s like a foreign language.” Another common word that was
used was “confusing.” One beneficiary went so far as to say, regarding the statements he
received from Medicare Part D, “Now me, I probably get the bill in the mail, I might
throw it away, but really, I’m not neglecting the bill, like I’m not going to pay it…but, I
just, you know, I can’t afford it.” These statements were not actually bills, but the
beneficiary did not understand their purpose and was throwing them away because he felt
that he could not afford another medical bill.
Several participants who reported that the Medicare Part D information was
helpful stated that they routinely brought their statements to their caseworkers, who
helped them interpret the information. Those who found Part D information to be helpful
also seemed to appreciate the regularity with which statements and information came in
the mail to them. As one beneficiary said, “It’s like clockwork.”
Those who found Part D information not helpful also occasionally mentioned that
they brought their statements to their caseworkers. A couple of beneficiaries who found
the information not helpful had negative things to say about their case workers, seeming
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to indicate that these individuals were too busy to provide them with the information and
guidance they were seeking.
Very few participants mentioned using the Medicare Web site. A few mentioned
calling Medicare’s help line or calling their prescription drug plan for help with
problems. Those who mentioned that they had used the help lines stated that they
frequently were kept on hold for long periods of time and that they were still unable to
get the information that they needed, although some reported satisfaction with the
Medicare phone help line. “I just call…Medicare…and I tell them if I’m having a
problem what the problem is, and they tell me if it’s my problem or if it’s the doctor or
hospital’s problem.”
Paperwork itself was a slightly different theme in beneficiaries’ comments.
Beneficiaries seemed to say, “No problems, just paperwork.” Across the three agencies,
beneficiaries stated that there had been many forms to fill out and many letters sent from
their Part D plans, but most beneficiaries were not bothered by the amount of paperwork.
Again, many beneficiaries mentioned help from case workers. For example, “I wish they
would send me more information about my Medicare stuff, but my information comes
from the people here, at (mental health agency). What I would like is to get more
information through the mail.”
Satisfaction with generic medicines.
Opinions about the use of generic medicines by Part D plans varied. Many
beneficiaries noted that their Part D plans preferred to pay for generic medications. Most
of these beneficiaries thought that generics were okay, but those who had experienced
difficulties with generics were very vocal and concerned about this issue. One
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beneficiary commented, “See, I have pins and stuff in my legs, and they have me on,
like, this, it’s supposed to be like Vicodin, but it’s the generic, and it doesn’t work the
same; it really doesn’t, like, I have to take more of that, and, I would just take, like one of
the other, you know, and that’s the only problem I have with that, and see, most of my
pain medication that they give me is a generic. I think that’s the only problem I have,
you know, with that. When it comes to pain, chronic pain like that, we should be able to
get the right thing for it, you know.”
Those who did not mind generics felt that the fact that they could save money by
using generics was very important. A common theme among those who did not mind
generics was, “They’ve got the same potency (as the brand-name).” Another common
statement was, “It (the generic) works just the same.”
Among those who objected to generics, most had had a bad experience at one
point with taking a generic form of a medication. Others had experienced periods of
stability on brand-name medications and did not want to risk switching. Several
beneficiaries mentioned feeling somewhat threatened by their Part D plan—that they
would be forced to accept a cheaper medication instead of the brand name that was
working well for them. For example, one woman had been taking a name-brand
antipsychotic for five years and had stayed out of the hospital for that time; her Part D
plan sent her “memos” with her monthly statement encouraging her to discuss a cheaper
medication with her doctor. She was reluctant to do so because the name-brand drug had
worked so well for her, and no generic form of that particular medication was available.
In her own words, “Like Abilify, they keep telling me I need a prescription for something
different, because they say Abilify costs too high, in the market. I can’t—they ain’t got
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no generic for Abilify! I ain’t taking a different psychotic! Before I got started on
Abilify, I was in the hospital like every three months. I’m on Abilify now and I’ve gone
for five years and I ain’t been in the hospital!”
Pharmacy interactions.
Help from pharmacists came mostly in the form of waived co-payments.
Pharmacists also gave individualized help to beneficiaries when they ran out of medicines
at the end of the month, perhaps lessening the effect of quantity limits. As one
beneficiary stated, “If I, run into a problem like I did this past weekend—I ran out of
medications because I don’t see the doctor till today, and…the pharmacist at
(independent pharmacy) knows me, right? So he gave me eight days’ of medication.”
Interviewees also reported that the transition that had taken place between
Medicaid drug coverage and Medicare Part D had gone smoothly from the pharmacy
perspective. For example, “And none of it has changed, the medicines are all the same,
the companies may have changed, with the generics, and some of the generics look
different. And almost everything I get is a generic, but I don’t remember, if there was a
change, it was a smooth transition.”
Participants reported high levels of satisfaction with the customer service offered
to them at their pharmacies. They gave examples of personalized service and effective
communication with their pharmacists. One beneficiary said, “I go to (independent)
Pharmacy, and they know my medicines already, and I know the boss there; he knew me
when I was at (assisted living facility), so I will be able to get my medicines. Medicaid
and Medicare, they don’t bother me.”
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Beneficiaries were more likely to report individualized assistance from
independent pharmacies, but those who used chain pharmacies also seemed to be
satisfied. In fact, one participant who used a chain pharmacy reported the following:
“My pharmacy, dealing with them, they will help you find where you need to go. They
can be more compassionate, as far as providers that you come to, not only with these
mental health consumers but with other people. In terms of getting my medicine on time,
the pharmacy intervention, they were right there with me. I give them an ‘A’.”
Another participant commented about using a chain pharmacy, “I had to go to the
emergency room for my breathing. And I needed a prescription filled…and the hospital
prescription place at that time was overcrowded, and they couldn’t take me, so I had to go
to like (chain pharmacy) or someplace like this, and since (chain pharmacy) was open 24
hours, and it was close to where I lived, I got it taken there to get it filled, which was
great, you know.”
Mental health agency interactions.
The phrase, “I don’t have no problems” also appeared frequently when
beneficiaries were discussing help that they got from mental health agencies. Most
beneficiaries who received help from a nurse or social worker expressed confidence that
the helper could take care of whatever difficulty they were experiencing and resolve the
situation. For example “You know, I called my case manager; my case manager told me
what to do. So I did that, sent it in, they haven’t sent me another bill.”
However, a few (from one agency in particular) stated that although their
community support workers tried to be helpful, they were powerless to change the
system. One participant commented about her community support worker’s struggles by
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saying the following, “I have the best CSW in this place, who has advocated very
aggressively on my behalf. It is just that she is not able to do anything about it. The
problems that I’m having with my medications, and getting that straightened out, she is
still fighting for that.”
Mental health agency staff played a big role in making sure people got their
medicines. Beneficiaries reported that agency staff assisted with co-payment costs,
helped beneficiaries with picking up their medicines, helped to fill medicine planners,
and communicated with physicians’ offices when formulary problems arose. Several
beneficiaries reported that they took the statements that they received from Medicare
directly to their community support workers, so that they could get help in interpreting
and understanding the content of these documents. As one interviewee stated, “…the
wording of the things, it’s like, we’re supposed to understand (laughs). I don’t
understand, so, you know, that’s why I had to have help with it, you know. But like I
said, I’m fine with it now, you know; as long as I get my meds, I’m good (laughs).”
Another participant noted, “Well, I would say, my case manager said, tell me what to do,
put those numbers in, and send it in, and I haven’t received another bill.”
Community Support Worker Results
Four themes were identified throughout the community support worker coding.
They are as follows: Managing beneficiary problems, stress for beneficiaries,
information and paperwork issues, and concerns about health care reform.
Managing beneficiary problems.
Managing beneficiary problems was by far the most frequently-occurring theme
in the community support worker transcripts. One aspect of this involved direct action or
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advocacy that CSWs were taking on behalf of beneficiaries on Part D-related concerns.
CSWs mentioned that they spent a considerable amount of time side-by-side on the
phone or on the Medicare Web site, helping consumers to obtain the information that
they needed to use and make decisions about their prescription drug benefits. CSWs
stated often that they felt that consumers would have had a great deal of difficulty
managing these transactions on their own.
Problems also arose with physician interactions and with the process of plan
switching. Community support workers had to advocate on behalf of consumers with
their physicians to obtain changes in prescriptions or to obtain necessary information to
circumvent various utilization management issues that were standing in the way of
consumers’ getting their medicines. CSWs reported that dealing with physicians was
difficult due to delays in obtaining the information that they needed. For example,
“…that’s been one issue, getting the physicians to fill out needed paperwork. It’s an
issue, unless they really are hot for the medication to get it approved, you know.” CSWs
also reported that physicians in general had little awareness of the details of Part D and
were particularly lacking in knowledge regarding plan formularies: “It’s like the doctors
don’t know. They don’t know what’s covered and what’s not covered.”
In contrast to physicians, pharmacists were universally perceived by CSWs as
knowledgeable and helpful. As with beneficiaries, CSWs were more likely to bring up
specific examples of help provided by independent pharmacies, particularly the two
independent pharmacies with which their agencies had collaborative relationships.
However, they, too, also seemed satisfied with services provided by chain pharmacies.
As one CSW mentioned, “I think they, they’ve been working harder with our members
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and stuff than Medicaid or Medicare, with what was going on.” Regarding formulary
negotiations, another CSW stated, “They’re really good about, you know, calling and
trying to get things covered or at least trying to get something comparable to what’s not
covered.” CSWs frequently collaborated with pharmacists to ensure that their clients
were able to obtain the medicines they needed, both for physical and mental health needs.
“I think because of our situation, because we mostly work with (independent pharmacy),
a lot of those things were a lot smoother.”
Plan switching also brought up problems for CSWs in helping beneficiaries.
CSWs did not like the randomness of plan switching that occurred with the low-income
plans each year and found themselves having to go on line or call the various plans to
obtain formulary and premium information for beneficiaries’ assigned plans. The process
of going on-line to switch plans and obtain information was not easy for many CSWs to
negotiate, especially in the first year of the Medicare Part D program: “…there really
wasn’t anyone around to kind of help you navigate on the Internet and figure, and do the
formulary and all that stuff so you can actually sign up on-line. So that was, that was
kind of, it was kind of aggravating, but, like I said, after a couple of times of doing it, you
kind of figure it out.”
Community support workers did mention, however, that the overall
implementation of Part D had gone more smoothly than they had expected. They noted
that consumers’ medication coverage had not lapsed, and that access to medicines at a
low price was still a reality for almost all of their clients.
Stress for beneficiaries.
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Interestingly, community support workers perceived the Medicare prescription
drug program as confusing and frightening for beneficiaries, despite the fact that the
consumers themselves did not usually characterize the program this way. Community
support workers’ perception was that Part D was associated with a number of significant
problems for beneficiaries. Community support workers stated that the Medicare Part D
program was a source of anxiety for many consumers and that changes in formularies, the
large quantity of information sent by the plans, and the technical language used in plan
communications all caused problems for consumers. Regarding the language used by
plans, one CSW mentioned, “It’s like that weird medicalese and legalese, and the average
person—it’s not written for the average person to understand.”
There was a great deal of stress and anxiety related to transition points with the
benefit, as well; when consumers were switched from one plan to another, or when
formularies underwent changes. Community support workers noted that beneficiaries did
not have a clear understanding of which health care program was paying for which health
care benefits. One CSW stated, “I think it’s incredibly stressful for them because they
don’t know if the meds that they are on now are going to be covered under their plan,
and, uh, there’s a little stress on them, if they’re going to have to start paying a monthly
co-pay if they don’t switch plans…” Another CSW commented on the plan switching
process, “They say, you don’t have to do this, but they make it sound so bad, and you
have to pay so much money if you don’t, that you’re kind of forced into whatever they
want you to do.”
CSWs characterized consumers as “frustrated” and “confused” regarding their
health care benefits. This may have been a reflection of the workers’ own feelings in
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dealing with plan switches, formulary issues, and costs. CSWs mentioned several points
regarding their own confusion. “I mean, I find it difficult to understand, and you know,
for them, yeah, it’s like, if we’re having trouble understanding it, they’re like, it’s Greek
to them.” Another CSW stated, “I never understood when they first came out with the
whole Part D thing and we all got the information, and that was so confusing, and it was
terrible because you had these clients asking all these questions, and you’re like, I don’t
know, you know (laughter). Because I don’t get it either, which is not very comforting.”
Information and paperwork issues.
Community support workers were especially concerned with the volume of
paperwork associated with using the Medicare prescription drug benefit. One team
leader noted that the government “has wasted a lot of paper” on communications
associated with the prescription drug benefit. Community support workers did state that
they felt that Medicare and the Part D plan sponsors had improved over the past several
years in terms of communication and organization, but even as of 2010, some problems
remained.
One issue related to information and paperwork was the observation by CSWs
that beneficiaries frequently could not discern the difference between advertisements sent
to them by Medicare Advantage and Medicare prescription drug plans, and consumer
information related to their benefits. Beneficiaries had difficulty telling the difference
between communications from their plan to which they needed to respond and
advertisements attempting to recruit them into a new benefit plan. This led to some
beneficiaries’ enrollment in Medicare Advantage plans that limited their access to needed
medications and providers, and CSWs reported spending quite a bit of time dis-enrolling
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consumers from Medicare Advantage plans. One team leader noted regarding Medicare
Advantage plan promotions, “…misrepresenting themselves, to put it mildly, to a lot of
our members, and signing people up, and then, then they find that their doctors don’t take
it; they can’t use it to pay doctors, and, and, in the meantime they’ve kind of run up a
medical bill that the doctor can’t send to original Medicare.” A CSW mentioned similar
problems at her agency, “They (clients) get tripped up with the Advantage Care plans.
The Medicare Advantage plans. Because they see that and they think, well, I have to
switch to this, not realizing that, yeah, you gain some stuff, but you lose some benefits,
too.”
CSWs also observed that some beneficiaries’ distrust of “the system” and in some
cases, symptoms of paranoia, led to problems in using the Part D benefit. CSWs reported
that some consumers had concerns about identity theft and destroyed needed documents
related to their Part D plans. Other consumers were mistrustful of switches in
medications and coverage which led them to conclude that their medicines were being
“tampered with.”
A common theme among community support workers was that they resented the
time that they had to spend deciphering Part D paperwork and explaining consumers’
benefits to them. CSWs felt that this time could be better spent on other interventions
related to rehabilitation and community support. For example, “We have to spend so
much time, every year, going through this, these changes, and that’s time we could be
spending doing other things with our clients.”
Concerns about health care reform.
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Cynicism about health care reform efforts was common among these community
support workers. Their perception was that the current reform efforts underway at the
federal level were going to lead to more confusion and less access to affordable care for
their clients. They expressed a wish that the federal government would eliminate the
two-year waiting period for disabled adults to receive Medicare, but doubted that this
reform would actually take place.
One desire expressed by CSWs related to health care reform was the need for
better communication regarding Medicare and the prescription drug benefit. Several
CSWs noted that at the state level, representatives from the Division of Medical Services
had hosted town hall meetings and informational events to explain changes in Missouri
HealthNet benefits. These CSWs expressed the wish that representatives from Medicare
or from Part D plan sponsors would host similar forums for their consumers. CSWs felt
that this face-to-face communication from Medicare to the beneficiaries would eliminate
confusion and give consumers an opportunity to voice their concerns and opinions. One
team leader noted that a representative from a Medicare Advantage plan had hosted an
informational event at her agency, and that this had helped consumers to understand the
benefit better. There was a desire on the part of CSWs to have this information separate
from advertising or recruitment efforts related to specific plans, however.
Plan Comparison Data: Results
The purpose of the quantitative analysis was to use formulary and performance
data on the Part D program to compare plans on various attributes that contribute to
patient-centeredness. By evaluating the extent to which plans have attributes related to
patient-centeredness, it is possible to determine to some degree how well plans are

99

meeting the needs of adults with mental illness. Formulary and performance data were
used to answer questions about respect for patients’ needs and preferences, access to care,
information and education provided to patients, and coordination of care.
Part D Formularies
To examine the comprehensiveness of the formularies of the Part D plans, the
www.medicare.gov Formulary Finder was used. The following table outlines these
findings.
Table 4.7 Formulary Comprehensiveness
Plan
Aetna Medicare Rx
Essentials
Community CCRx
Basic
First Health Part DPremier
Health Spring
Prescription Drug
Plan-Reg 18
Medco Medicare
Prescription PlanValue

Anticonvulsants
Covered
100%

Antidepressants
Covered
100%

Antipsychotics
Covered
100%

80%

47%

82%

80%

47%

82%

87%

47%

91%

67%

47%

82%

The Medicare Rx Rewards Standard Plan is not included in this table because
formulary data for this plan were not available at the time that the data were being
collected. Coverage for anticonvulsants is quite comprehensive with the first four plans
examined, although Medco Medicare Prescription Plan-Value covers only 2/3 of the
anticonvulsants in Huskamp et al.’s list. Coverage for antidepressants does not appear to
be as good, with four of the five plans covering less than half of antidepressants on the
list. However, many of the antidepressants that are not covered are those brand-name
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drugs that have generic equivalents at this time, such as Celexa, Prozac, and Paxil.
Coverage for antipsychotics is fairly good, with the lowest percentage of antipsychotics
covered at 82% for three of the five plans. Coverage for anticonvulsants and atypical
antipsychotics may be better than coverage for antidepressants because there are fewer
generic alternatives for many of the anticonvulsants and antipsychotics than there are for
the antidepressants. This is consistent with the Centers for Medicare and Medicaid
Services regulation stating that “all or substantially all” drugs in these classes must be
covered by all Part D plans (Huskamp, 2007).
Aetna Medicare Rx Essentials covers all of the three classes of drugs listed, but this
plan also uses quantity limits for almost all antidepressants and antipsychotics on the list.
Part D Utilization Management Strategies
The www.medicare.gov Formulary Finder was also used to identify which
utilization management strategies are being used by each Part D plan. Utilization
management strategies are processes used by prescription drug insurance plans to limit
coverage of expensive medications. The three primary utilization management strategies
used by Part D plans are prior authorization, quantity limits, and step therapy. Prior
authorization is used when a Part D plan requires written permission from a beneficiary’s
prescribing health care provider before a particular drug will be prescribed. Quantity
limits are enforced when a beneficiary can only receive a certain quantity of medication
during a specified time period. For example, a beneficiary may be limited to obtaining
thirty tablets of a medication during a 30-day period. Step therapy, also known as “failfirst,” occurs when a beneficiary must provide evidence to his/her prescription drug plan
that a less expensive medication is ineffective for him/her before a more expensive
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(usually brand-name) medication will be covered. The following table outlines the
percentage of each class of medications that is subject to each form of utilization
management.
Table 4.8 Utilization Management Strategies
Plan

Prior

Quantity Limits

Step Therapy

Authorization
Aetna Medicare Rx
Essentials

Anticonvulsants

0%

13%

7%

Antidepressants

0%

100%

68%

Antipsychotics

0%

81%

27%

Anticonvulsants

8%

17%

0%

Antidepressants

0%

56%

22%

Antipsychotics

11%

100%

0%

Anticonvulsants

8%

17%

0%

Antidepressants

0%

33%

11%

Antipsychotics

56%

89%

0%

Community CCRx
Basic

First Health Part
D-Premier
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HealthSpring
Prescription Drug
Plan –Reg 18

Anticonvulsants

0%

0%

0%

Antidepressants

0%

78%

0%

Antipsychotics

0%

80%

0%

Anticonvulsants

0%

0%

0%

Antidepressants

0%

100%

0%

Antipsychotics

0%

78%

0%

Medco Medicare
Prescription PlanValue

Prior authorization was used relatively infrequently by all five plans The highest
use of prior authorization can be seen with First Health Part D-Premier, in its coverage of
antipsychotics, in which 56% of atypical antipsychotics covered by the plan require prior
authorization from a health care provider before the plan will pay for them. When prior
authorization is used, it is often used with brand-name drugs that are quite expensive and
that have no generic alternative.
Quantity limits were the most commonly-used utilization management strategy,
employed by all five of the plans. Quantity limits were especially common in coverage
of antidepressant medications; two of the five plans required quantity limits for all
antidepressant prescriptions, and two additional plans required quantity limits for more
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than half of antidepressant prescriptions. Quantity limits were also frequently employed
with atypical antipsychotic medications, with all five plans using quantity limits for over
three-quarters of atypical antipsychotic prescriptions. For most patients, the use of
quantity limits does not affect access to the medicines they need, but for patients who
require more than one daily dose of a particular medicine, quantity limits can create a
problem.
Step therapy was not used at all by two of the five plans. Aetna Medicare Rx
Essentials required step therapy for about two-thirds of antidepressants. Community
CCRx and First Health Part D-Premier used step therapy for a small number of
medications. Plans may use step therapy because they want patients to try cheaper
medications first before switching to expensive brand-name drugs. Both prior
authorization and step therapy require considerable documentation and paperwork on the
part of patients’ physicians.
There is a certain amount of interplay between formulary coverage and use of
utilization management tools. Some plans take the approach that they will have all drugs
on formulary, but will restrict their use through quantity limits or step therapy (for
example, Aetna Medicare Rx Essentials). Other plans have more limited formularies, but
they do not use utilization management tools as extensively (for example, Medco
Medicare Prescription Plan).
Medicare Part D Performance Data
The Medicare Part D performance data were used to answer three questions
related to the patient-centeredness of the benchmark plans. The first question was: What
percentage of plan members feel that the drug plan provides information or help when
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members need it? Adequate information and education about health care has been
identified as a key aspect of patient-centered care. The following table summarizes the
percentage of members in each plan who expressed satisfaction with the information and
education provided by their plan.
Table 4.9 Provision of Information and Help When Members Need It
Plan
Aetna Medicare Rx Essentials

Percentage of plan members who feel that the plan
provides information or help when members need it.
77.7%

Community CCRx Basic

76.8%

First Health Part D-Premier

79.1%

Health Spring Prescription
Drug Plan-Reg 18

79.0%

Medco Medicare Prescription
Plan-Value

80.4%

Medicare Rx Rewards
Standard

75.4%

Over three-quarters of members in every benchmark plan felt that information and help
was provided by the plan when they needed it. The lowest percentage was Medicare Rx
Rewards Standard, for which 75.4% of members expressed satisfaction with information
and help provided by the plan. The highest percentage was Medco Medicare Prescription
Plan-Value, for which 80.4% of members expressed satisfaction with information and
help provided by the plan. There is so little variation that the question of patients’
diligence in reporting problems and satisfaction is raised.
A second question that was asked using the Medicare Part D performance data
was: What is the rate of complaints about drug plan benefits and access to prescription
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drugs? This is an important question because it touches on levels of satisfaction
regarding beneficiaries’ ability to obtain certain medications and to use their benefits to
get what they need. The rate of complaints in this area was extremely low across all of
the plans studied. This may be because patients do not complain to the Centers for
Medicare and Medicaid Services when they have problems with their plans. Patients may
not even realize that they have the right to register a complaint. Alternatively, it may also
be because most people are getting what they need from Part D.
Table 4.10 Rate of Complaints About Drug Plan Benefits and Access to Prescription
Drugs
Plan

Rate of complaints (per 1000 members)

Aetna Medicare Rx Essentials

0.07

Community CCRx Basic

0.04

First Health Part D-Premier

0.07

HealthSpring Prescription Drug Plan-Reg

0.05

18
Medco Medicare Prescription Plan-Value

0.04

Medicare Rx Rewards Standard

0.05

The third question examined using Part D performance data was as follows:
What is the rate of complaints about joining or leaving specific prescription drug plans?
This is a particular issue for dually-eligible beneficiaries because they may be randomly
assigned to plans that are not the best “fit” for their needs and may need help switching to
a plan that has a more appropriate formulary or pharmacy network.
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Table 4.11 Rate of Complaints about Joining or Leaving Specific Prescription Drug
Plans
Plan

Rate of complaints (per 1000 members)

Aetna Medicare Rx Essentials

0.61

Community CCRx Basic

0.39

First Health Part D-Premier

0.87

Health Spring Prescription Drug Plan-Reg

0.31

18
Medco Medicare Prescription Plan-Value

0.61

Medicare Rx Rewards Standard

0.37

Rates of complaints about this aspect of the prescription drug plans appeared very
low, as well, although they are higher than rates of complaints about benefits and access.
As with complaints about access and benefits, patients may not be aware of the
mechanisms for registering complaints with CMS. In addition, there may be few
complaints because patients do not switch plans very often (Dulio, Perry, & Cubanski,
2007).
Conclusion
The qualitative and plan comparison data examined here offer a look inside the
world of the Part D benefit. That world is characterized by satisfaction on the part of
beneficiaries, and cynicism on the part of community support workers. The plan
comparison data reinforce the high levels of beneficiary satisfaction.
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The overwhelming perspective of beneficiaries seems to be that Medicare Part D
works well in providing low-cost, accessible prescription medications. Though
satisfaction is high and complaints are low, there are still a few access issues, as well as
problems with information and education about plans. However, the impact of existing
problems with Medicare Part D appeared to be moderated by the assistance provided by
community support workers and pharmacists. Interviewees frequently mentioned the
importance of the help they received in being able to use their prescription drug benefits.
Beneficiaries acknowledged the extensive assistance they received both from mental
health agencies and from pharmacies in using their Part D benefits and accessing their
medications. The consistent mention of the critical role of this help came as a surprise.
Community support workers were much more likely than beneficiaries
themselves to mention problems with access and plan information. Many community
support workers had experienced problems with plan switching and with confusing
information provided by plans. Community support workers reported spending
considerable amounts of time deciphering plan information and negotiating the Medicare
Web site with their clients. An attitude of cynicism and frustration permeated CSWs’
discussion not only of the Part D program, but of national health reform efforts, as well.
Plan comparison information revealed only a few complaints about the Part D
program. In some respects, the plan comparison data painted an even more positive
picture of the patient-centeredness of the Part D program than even the qualitative
findings from beneficiaries. The low incidence of complaints about Part D plans was
somewhat surprising. Formularies appeared to cover the majority of psychotropic
medications, but there were some access issues concerning brand-name drugs that
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affected a few beneficiaries. Utilization management tools, especially quantity limits,
were a common cost-containment strategy for Part D plans. Satisfaction with
information provided appeared high overall, and rates of complaints about benefit plans
and plan switching were extremely low. Examination of the plan comparison data in
light of the qualitative findings will reveal further insights into the patient-centeredness of
the Medicare Part D program.
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CHAPTER V: DISCUSSION AND CONCLUSIONS
Introduction
This chapter discusses the qualitative and plan comparison findings and their
relationship to patient-centered care. Principles of patient-centered care are compared
with codes discerned in the qualitative data, as well as with findings related to the plan
comparison data. Focus group and interview data are triangulated with plan comparison
data to determine whether “benchmark” plans are adhering to important principles of
patient-centered care. Following this discussion, the findings are summarized, and
implications for social work research, policy and practice, and education are outlined.
Qualitative Data Analysis: Consumer Codes and Patient-Centeredness
After stakeholders’ experiences with the Medicare program were coded and
sorted, data were examined to discover relationships between experiences with Medicare
Part D and principles of patient-centered care. A deductive approach was used; concepts
related to patient-centered care were used to organize and understand the data codes
(Morse & Field, 1995). With the consumer data, each code was found to relate to at least
one patient-centered care characteristic, as seen in the following table.

110

Table 5.1. Consumer Data Codes and Patient-Centered Care Principles

Data Code
Concerns about health care reform
Co-payments okay
Co-payments not okay
Costs okay
Costs not okay
Dental insurance problems
Formulary problems
Generic drugs okay
Generic drugs not okay
Help from mental health agencies

Help from pharmacists

Information from Medicare helpful
Information from Medicare not helpful
Medicaid spend-down

Not satisfied with Part D
Satisfied with Part D
Paperwork
Problems with Medicare Advantage
Problems with utilization management (in Part
D plans)

Patient-Centered Care Principle(s)
Information and education
Access to care (there is not a patient-centered
care principle directly related to cost)
Access to care
Access to care
Access to care
Respect for the patient’s values, preferences
and expressed needs; access to care
Respect for the patient’s values, preferences
and expressed needs; access to care
Respect for the patient’s values, preferences,
and expressed needs; access to care
Respect for the patient’s values, preferences,
and expressed needs; access to care
Information and education; emotional support
to relieve fear and anxiety; continuity and
secure transitions between health care settings;
coordination of care
Information and education; continuity and
secure transitions between health care settings;
coordination of care
Information and education; coordination of
care
Information and education; coordination of
care
Access to care; continuity and secure
transitions between health care settings;
coordination of care
Respect for the patient’s values, preferences,
and expressed needs
Respect for the patient’s values, preferences,
and expressed needs
Information and education; coordination of
care
Access to care; coordination of care
Respect for the patient’s values, preferences,
and expressed needs; access to care
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Patient-centered care principles are relevant to the concerns of individuals with
serious mental illness because there are so many similarities between the concept of
patient-centered care and principles of quality mental health care (Mechanic, 2007;
Pincus et al., 2007). The most critical principles of patient-centered care for adults with
serious mental illness, according to this analysis, appear to be access to care (which
includes affordability); respect for the patient’s values, preferences, and expressed needs;
and information and education.
Another reason that patient-centered care principles are important to adults with
serious mental illness has to do with the impact of mental illness stigma. The stigma of
mental illness has left many adults with mental illness disempowered and disenfranchised
(Corrigan, Watson, Byrne, & Davis, 2005). When health care programs enact principles
of patient-centered care, they can accomplish much to undo the harmful effects of stigma.
Respect for patients’ values, as well as information and education, are particularly
important in this regard.
Consumers’ Assessment of Patient-Centeredness of Medicare Part D
In terms of access and attention to individual patients’ needs, beneficiaries gave
the Part D program high marks. With a few exceptions, most beneficiaries felt they were
able to obtain their medicines through Part D inexpensively and without much hassle: “I
don’t have a problem getting my medicine” and “Part D is working for me.” This is
congruent with the observations of Neuman and Cubanski (2009) regarding low-income
subsidy-eligible beneficiaries, who had lower out-of-pocket costs than they had had under
Medicaid. Duggan et al. (2008) also note that overall, Medicare Part D has increased
access to prescription medicines for beneficiaries. Qualitative observations from the
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“Voices of Beneficiaries” project also note high overall satisfaction with Part D access
and cost (Kaiser Family Foundation, 2006; Perry et al., 2006). Though there were a few
complaints about access to brand-name medications, for most beneficiaries this was not a
problem.
In terms of information and education related to Part D plans, beneficiaries were
not as satisfied. Though some consumers appreciated the information provided by Part D
plans, others found the amount of paperwork confusing. Some beneficiaries found plan
communications to be helpful in deciphering their benefits, but others felt that the
language used in statements sent by plans was not easily understood. As one interviewee
noted, “It was hard for me to understand the way that some of that, the way they word it,
you know, it’s really difficult.” Dulio, Perry & Cubanski (2007), in their interviews of
Part D beneficiaries, found similar results—that beneficiaries had difficulty
understanding paperwork associated with the benefit.
The “piece of the puzzle” that seemed to make the prescription drug benefit
manageable for these beneficiaries was the extensive help they got from pharmacists and
workers at community-based mental health agencies. This help from pharmacies and
mental health agencies was directly associated with the patient-centered care attribute of
continuity and secure transition between health care settings. This assistance made the
program more patient-centered for participants, enhancing perceptions of respect for
patients’ values and needs, as well as access to care. As one beneficiary mentioned about
his pharmacy, “I guess I don’t have a problem. They (the pharmacists) know who I am
when I call.” The Part D benefit itself did not adhere so well to expectations of patientcenteredness, but the assistance provided by community helpers definitely seemed
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focused on the well-being of the consumers. Perry, Dulio and Cubanski (2006) also
mention the role of pharmacists as advocates for Part D beneficiaries, and an earlier
Kaiser Family Foundation report (2006) discusses the role of community-based case
managers in assisting with plan selection. Shrank et al. (2006) mention the assumption of
many physicians that it is the role of pharmacists to assist patients in managing costs. In
terms of managing the stress and anxiety associated with Part D, as Zagar states, “The
technical components of Medicare Part D can be ‘learned,’ but the emotional aspects
associated with this program can only be ‘experienced.’” (2007, page 5). Community
support workers and pharmacists not only provided the technical help with interpreting
benefits and obtaining medications; they also supported beneficiaries and lessened
anxiety and confusion about use of the program.
Qualitative Data Analysis: CSW Codes and Patient-Centeredness
CSW codes were also mapped onto patient-centered care characteristics using a
deductive theory approach.
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Table 5.2 Community Support Worker Data Codes and Patient-Centered Care Principles
Data Code
Action on behalf of consumer

Communication with members
Costs Not Okay
Costs Okay
Dealing with Bureaucracies
Health Care Reform
Part D Okay
Pharmacies helpful

Prescription Issues
Problems with Medicare
Advantage
Problems with physicians
Problems with Switching Plans
Stress for consumers
Utilization Management

Patient-Centered Care Principle(s)
Information and education; emotional support to
relieve fear and anxiety; continuity and secure
transitions between health care settings;
coordination of care
Information and education; coordination of care
Access to care
Access to care
Information and education; coordination of care
Information and education
Respect for the patient’s values, preferences, and
expressed needs
Information and education; continuity and secure
transitions between health care settings;
coordination of care
Respect for the patient’s values, preferences, and
expressed needs; access to care
Access to care; coordination of care
Coordination of care; continuity and secure
transitions between health care settings
Coordination of care; access to care
Information and education; access to care;
emotional support to relieve fear and anxiety
Respect for the patient’s values, preferences, and
expressed needs; access to care

Community support worker codes were mapped onto patient-centered care
principles because CSWs play a critical role in ensuring that beneficiaries experience
health care in a patient-centered way. The concept of client-centeredness has been used
to assess the quality of public social services, and is considered important in
understanding reasons for clients’ satisfaction with such programs (Jindani & Murdock,
2009). The most important principles of patient-centered care for the community support
workers interviewed for this study appear to be access to care, coordination of care, and
information and education. Coordination of care appears as a prominent principle of
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patient-centered care for these CSWs, most likely because they play such an important
part in coordinating programs for the beneficiaries they serve.
CSWs’ Assessment of Patient-Centeredness of Medicare Part D
Community support workers were not as positive as beneficiaries in their
evaluation of the Medicare prescription drug benefit. CSWs felt that continuity and
secure transition between plans and between formularies was lacking, and that they were
frequently called upon to make these transitions happen. Community support workers
were almost entirely negative about the information and education provided by Part D
plans, feeling that there was too much of the wrong kinds of information. CSWs noted
repeatedly that they themselves had difficulty understanding communications from Part
D plans, and they observed that individuals with less education or lower literacy would
have an even harder time deciphering plan information. As one CSW stated, “For me, I
know it was confusing for a lot of people.” Another CSW recommended, “Give
members greater understanding. Members want more information.”
Community support workers expressed cynicism and frustration with the
operation of Part D plans, and even though CSWs noted that the implementation of Part
D had not been quite as chaotic as they had expected, there were still substantial
problems with plan communications. Nonetheless, in terms of access to care, community
support workers did note that beneficiaries were able to obtain their medicines cheaply
and that few lapses in coverage had actually taken place. One community support worker
noted, “But as far as their psych meds, everything’s pretty much covered; um, their
regular medical meds are pretty much covered. We haven’t had too many issues.” The
resounding theme of CSWs’ comments, however, was that consumers would not be able
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to manage this benefit on their own. Not only instrumental help, but the emotional
support to relieve consumers’ fear and anxiety, were viewed as essential to assisting
consumers to manage the Part D program. A CSW mentioned, “It’s scary for someone
who’s paranoid already.”
Community support workers put a great deal of effort into making the Part D
benefit plan work well for their clients, but they rated the Part D plan quite poorly in
terms of continuity of care and access to care. These findings are similar to the
observations of Buchsbaum et al. (2007), who found in their key informant interviews
that health care and social service professionals had to provide much assistance to duallyeligible beneficiaries related to Medicare Part D. From case managers’ perspectives,
beneficiaries experienced satisfactory access and continuity/secure transitions because of
the assistance they received; for example, “It took hours and hours to, on the computer,
with the member sitting next to me, to plow through the system and try to get some
information.”
Plan Comparison Data: Discussion
Plan comparison data were used to assess five different patient-centered care
characteristics. These were as follows: Respect for the patient’s values, preferences, and
expressed needs (formulary coverage); access to care (use of utilization management
tools); coordination and integration of care (complaints regarding plan benefits);
information, communication, and education (satisfaction with plan information); and
transition and continuity (complaints regarding plan switching).
Formulary coverage is a key dimension of respect for patients’ needs. Formulary
restrictions are commonly used by both commercial and publicly-funded prescription
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drug plans to control costs, and some research shows that the cost-containment function
of formulary restrictions is fairly effective (Maio, Pizzi, Roumm, Clarke, et al., 2005). In
terms of formulary coverage of psychotropic medications in the six benchmark plans
studied, most plans appeared to have fairly comprehensive coverage. The only exception
to this was that certain brand-name antidepressants which have generic equivalents were
not covered. This creates a problem for beneficiaries who cannot tolerate generic
preparations, but for most patients this is not an issue. In the qualitative data collected
regarding use of generic medicines, most beneficiaries appeared satisfied with generic
preparations. One beneficiary did state that generic medicines were not effective for her,
and that her physician had specified that she should take a brand-name drug. Duggan et
al. (2008) mention that Part D plans frequently put in place strong incentives for
beneficiaries to used generic medicines; for most beneficiaries, this is not viewed as a
problem. Huskamp (2003) has noted that therapeutic substitution of one mental health
drug for another is less easily done than with drugs for other medical conditions, but for
most of the beneficiaries in the qualitative sample, this was not an issue.
Focus group participants—both beneficiaries and community support workers—
agreed that plan formularies rarely caused a problem for them, as the medicines
beneficiaries needed were almost always covered. Plans did reasonably well in
respecting the patient’s values, preferences, and expressed needs. The “incented
formulary” (Maio et al., p. 121) structure of these plans—placing generic and brandname drugs on different tiers of coverage—did not bother most beneficiaries and seemed
to serve their needs reasonably well, as even co-payments for brand-name preparations
were fairly low and often waived by pharmacies.
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Use of utilization management tools varied among the plans. The only utilization
management tool mentioned often by beneficiaries was quantity limits. According to
Olson (2003), quantity limits are frequently used by commercial pharmacy benefit plans
as a way to contain costs. Though they are somewhat effective at managing prescription
drug spending, quantity limits can create problems. For example, one study found an
association between plans’ use of quantity limits and transfers of beneficiaries to higher
levels of care (Olson, 2003).
In the focus group data collected, one beneficiary in particular had experienced
difficulty obtaining adequate amounts of an antidepressant she needed. She reported that
this had resulted in an unwanted hospitalization. Several other participants reported
encountering quantity limits in prescriptions for medical conditions, such as
hypertension. Beneficiaries saw quantity limits as unfair, feeling that the insurance
company should not have the right to specify how much medicine their doctors could
prescribe for them. Community support workers also reported problems with quantity
limits, stating that when their clients dropped or lost medicine, or were “overcompliant,”
they could run out of medicine and not be able to obtain more when they needed it.
The literature on utilization management tools in pharmacy benefit plans makes
frequent mention of prior authorization as a cost-control strategy (Olson, 2003; Maio et
al., 2005). Prior authorization is seen as effective at reducing utilization of new and
expensive medications, but it involves a considerable administrative burden that can
actually increase costs to prescription drug plans (Olson, 2003). This additional
administrative cost is one likely explanation for the infrequent use of prior authorization
among the Part D benchmark plans studied.
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In terms of access to care, plans frequently used utilization management,
especially quantity limits, to control costs. Some beneficiaries were upset by this, but
overall, utilization management was not a common barrier to obtaining the medicines that
beneficiaries needed or preferred. This is in contrast to the observations of Donohue et
al. (2009) who stated that implementation of utilization management tools for
psychotropic medications was likely to increase.
Medicare Part D performance data revealed some interesting information about
consumer satisfaction with several aspects of their prescription drug benefits. One of the
most fascinating aspects of these data is the overwhelmingly high levels of satisfaction
with Part D plans expressed by beneficiaries. This is in contrast to much of the literature
on satisfaction with managed care plans, which indicates that benefit plans that highly
“manage” (Landon, Rosenthal, Normand, Frank, et al., 2008) provision of services to
beneficiaries tend to have lower satisfaction ratings (Schur, Berk, & Yegian, 2004;
Landon et al., 2008). Gillies, Chenok, Shortell, Pawlson, & Wimbush (2006) also found
that affiliation with a national managed care organization (a frequent feature of Part D
plans) was correlated with lower patient satisfaction ratings. One interesting assessment
of consumer satisfaction with managed care, however, found that the level of care
management in benefit plans did not affect the satisfaction ratings of patients with
depression (Grembowski, Paschane, Diehr, Katon, et al., 2007).
In terms of satisfaction with information and help provided by plans, over threequarters of plan respondents stated that they were satisfied with these aspects of their Part
D plans. These results correspond well with the qualitative data on overall levels of
satisfaction that were collected, in which very few beneficiaries expressed dissatisfaction
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with their Part D plans. The rate of satisfaction with plan information and help seems
somewhat high compared to the qualitative question of plan information, in which about
half of beneficiaries reported having some problem understanding or interpreting
information they received from their plans. However, the qualitative data come from a
small and non-representative sample, so a discrepancy between the qualitative data and
the Part D performance data is not unexpected. Beneficiaries polled by the Centers for
Medicare and Medicaid Services expressed high levels of satisfaction with plan
information, and there was little variation among the plans. Beneficiaries surveyed were
mostly happy with the information provided by their plans. An interesting discovery
about communication is that a higher percentage of people are satisfied with their drug
plan’s communication with them than are satisfied with their physician’s communication
with them (CMS, 2009, AHRQ, 2008). The qualitative results are definitely more mixed,
it may be that the Part D program appears to be doing well on information,
communication, and education for beneficiaries largely because of the help that
beneficiaries receive from pharmacists, nurses, and community support workers.
Another question asked of the plan comparison data concerned the rate of
complaints among plans regarding plan benefits and coverage. Complaints about plan
benefits appear to be very infrequent in all plans. There is very little variation among
plans with this question. In the qualitative findings explored in this study, it did appear
that most beneficiaries questioned about formulary and access issues appeared highly
satisfied about this aspect of their prescription drug plans. Beneficiaries reported being
able to obtain the medicines they needed from their chosen pharmacies. Some
coordination and integration issues arose with plans during the switch in 2006 from
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Medicaid to Medicare for dually-eligible beneficiaries. Coordination and integration of
care, though noted in the qualitative findings as a source of some initial problems for
beneficiaries and case managers, did not appear as an area of difficulty in the plan
comparison data. The rates of complaints regarding plan benefits and ability to obtain
prescription medications were very low. This is a positive finding for beneficiaries with
mental illness, as Simoni-Wastila et al. (2008) found that Medicare beneficiaries with
severe mental illness were less likely to obtain prescription drugs for their mental health
conditions if they had discontinuities in their drug coverage. A finding of adequate
coverage and benefits for Medicare beneficiaries is also positive because limits on
prescription drug coverage can be associated with non-adherence and later health
problems (Hsu et al., 2006).
The final question that was asked of Part D performance data concerned the rate
of complaints about plan switching. There is more variability among plans on this
question, but rates of complaints are still very low. Although beneficiaries did not
frequently mention problems with plan switching during the qualitative data collection
for this study, community support workers did mention plan switching as a source of
stress both for themselves and for the beneficiaries they were working with. Community
support workers noted that using the Internet to switch a beneficiary’s plan could be a
confusing process for the client. It may be, however, that beneficiaries and their helpers
are not using formal avenues for filing complaints to register the problems they are
having with the plan switching process. Transition and continuity were sources of some
complaints on the part of beneficiaries, as they noted some problems with the plan
switching process. This appeared as a bit of a flashpoint in the qualitative data for CSWs,
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as well, as they mentioned frequently problems with plan switching among their clients.
Neuman and Cubanski (2009) have noted that the random assignment of dually-eligible
beneficiaries to benchmark plans can be a source of trouble and confusion.
Summary of Findings
The goal of this study was to use the framework of patient-centered care to gain a
better understanding of how well Medicare prescription drug policy meets the needs of
beneficiaries with severe and persistent mental illness. Eliciting the perspectives,
experiences, and opinions of Medicare Part D stakeholders has illuminated the various
policy dimensions that are considered the most important in prescription drug benefit
plans. A look at data comparing “benchmark” plans confirmed the opinions and
experiences of beneficiaries and their helpers.
Several conclusions can be drawn from the findings of this study. One important
observation is that low-income beneficiaries with mental illness express high levels of
satisfaction with the Medicare Part D program. Beneficiaries report few problems with
the benefit and seem, for the most part, to accept the costs and paperwork associated with
the Part D benefit.
For dually-eligible beneficiaries, the switch to the Medicare prescription drug
program from Medicaid has not meant big problems, but it has not improved access or
affordability (Donohue & Frank, 2007). Beneficiaries report high levels of satisfaction
with their prescription drug benefits, and they do not report many problems with
obtaining medications as a result of switching from Medicaid to Medicare. Costs seem
about the same. In addition, there is much more paperwork and bureaucracy to deal with
than there was under a single state-administered program (Hall, Kurth, & Moore, 2007).
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Beneficiaries report receiving monthly statements from their prescription drug plans,
enabling them to track more closely their prescription drug expenses but also giving them
one more piece of paper to read each month. Communications from Medicare and Part D
plans are appreciated, but not always experienced as readable or ultimately very helpful.
It is important to note, too, that for low-income people using Medicare Part D,
access often equals affordability. Comments about how much things cost were much
more prominent than other access-related concerns such as pharmacy networks. This
may have been because their pharmacies accepted their plans, or because under current
Part D regulations “all or substantially all” of mental health drugs must be covered by
plan formularies (Huskamp et al., 2007). Major patient-centered care themes for
beneficiaries were access to care; information, communication, and education; and
continuity and secure transitions.
Beneficiaries with mental illness used the services of their community support
workers extensively. Case workers are spending a great deal of time and energy on the
paperwork associated with this benefit program. This is a source of frustration for
community support workers, who would like to spend their efforts on more fruitful
rehabilitative services.
Community support workers’ perspective on this benefits program is quite
different from that of beneficiaries. Though Medicare beneficiaries did not mention
stress associate with using their prescription drug plan, community support workers
perceived Part D as a source of stress for their clients. Also, a frequent theme in CSWs’
comments about this program was dealing with problems associated with the benefit.
Problems included issues with paperwork and bureaucracy, communication with other
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professionals, and plan switching. Community support workers noted frequently the
importance of emotional support to relieve fear and anxiety, as well as adequate plan
information and communication, to effective use of the Part D program.
When examining plan comparison data, it appears that formulary coverage for
most psychotropic medications is quite good. Plans do use some utilization management
tools to control costs. Data on plan complaints and plan satisfaction seem to confirm
what consumers have to say about Part D; that is, that most beneficiaries are satisfied
with most aspects of their benefit plans. It is difficult to say whether these high levels of
satisfaction truly reflect beneficiaries’ experiences with Part D, or whether beneficiaries
are not empowered enough to register their complaints. Participants in the qualitative
focus groups and interviews, however, seemed reasonably empowered to express their
opinions, and they did report overall satisfaction with the Part D program. Plan
comparison information does seem to capture the most relevant aspects of patientcentered care for beneficiaries and their helpers, with the exception of emotional support,
which neither Medicare Web site nor Part D performance data are able to describe
adequately.
Conclusions: Is Medicare Part D A Patient-Centered Program?
To assess the patient-centeredness of the Medicare Part D program, it is beneficial
to re-visit the five attributes of patient-centered care identified by the investigator as
applying to patient-centered programs (see pp.46-47) . These are accessibility, care
coordination, involvement of the patient, information and education, and secure
transitions. These will be considered one at a time to determine how they apply to
Medicare Part D.
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Accessibility
Access comprises several different ideas, including affordability as well as ability
to obtain needed medications. In terms of affordability of care, Part D seems to meet this
criterion of patient-centeredness. Neither beneficiaries nor community support workers
reported major issues with co-payments or other issues related to affordability. In
addition, access to needed medications was generally perceived as acceptable. Only a
few beneficiaries reported problems with generic medications or formularies.
Beneficiaries who were participating in the Medically Needy (“spend-down”) program or
who had mistakenly enrolled in Medicare Advantage plans reported some access
problems, but these were not frequent complaints.
Care Coordination
Beneficiaries experienced coordination of care, but it was not due to any effort by
Medicare Part D plans or the Medicare program itself. Care coordination was a function
of the persistent advocacy of community support workers and other helpers on behalf of
their clients. Community support workers in particular noted that coordination between
Medicare and Medicaid programs was lacking, and beneficiaries often had little
awareness of which program was paying for what health care service. Medicare Part D
does not offer much coordination of care to beneficiaries.
Involvement of the Patient
Through Web-based tools such as the formulary finder and on-line plan
enrollment, Part D attempts to involve patients in choices about their own care. The Part
D program has made an effort to empower patients to make plan decisions.
Unfortunately, these Web-based sources of choice and information are often not
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accessible to the most economically vulnerable Medicare beneficiaries. Low-income
Medicare beneficiaries with mental illness reported that they rarely used the Internet to
make plan comparisons or enroll in Part D plans. Community support workers had
become adept at using the www.medicare.gov Web site out of necessity, but involvement
of CSWs does not equate with involvement of beneficiaries. Beneficiaries were autoenrolled into Part D plans in 2006 and again as the “benchmark” status of their plans
changed, and they rarely challenged or changed these enrollments unless urged to do so
by a community support worker.
Information and Education
Again, through Web-based resources, the Medicare program is attempting to
provide information and education to Medicare beneficiaries. Monthly statements also
provide communication from Part D plans to their enrollees. Information from plans and
from Medicare remains confusing, however, and in the case of Web-based information,
largely inaccessible to those who need it most. The Medicare Part D program needs
much improvement in the area of keeping beneficiaries informed and educated.
Secure Transitions
By auto-enrolling dually-eligible beneficiaries into “benchmark” Part D plans, the
Medicare program did ensure continuity of care for these individuals as they transitioned
from Medicaid to Medicare. Auto-enrollment each year as benchmark plans change also
ensures secure transitions. However, random plan assignment does not always ensure
that beneficiaries are enrolled in the plan that best suits their needs. That said,
beneficiaries registered few complaints about plan switching in the Part D performance
data.
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Limitations
This study is limited by the fact that the qualitative sample was composed of a
convenience sample of beneficiaries and community support workers from a very
specific agency context in the City of St. Louis, Missouri. All three of the agencies from
which participants were drawn have a reputation in the community for excellent case
management services, which may have affected the findings. Beneficiaries from these
three agencies may receive more services, of a higher quality, than community mental
health clients at other agencies or in other parts of the United States.
There were some limitations to the use of a volunteer sample for the focus groups
and interviews. Some of those who volunteered to participate in these groups and
interviews were individuals who have had particularly negative experiences with
Medicare, and who were looking for a forum in which they could air their complaint.
Some participants may have offered to take part so that they could obtain the gift card,
snacks, and bus passes that were offered to all who took part, even though they did not
have particularly well-thought-out opinions about Medicare. The author attempted to
minimize this possibility by emphasizing in recruitment materials that participants needed
to have experience with the Part D program, and that the research was focused on looking
for perspectives and opinions about that program.
An additional limitation was that several of the focus groups were quite small,
involving only two or three individuals. However, Toner (2009), in a recent article on
qualitative methods, has pointed out the value of very small focus groups in eliciting deep
yet focused information from participants. In addition, with participants who had a
diagnosis of mental illness, smaller focus groups actually functioned extraordinarily well
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and enabled interviewees to stay closer to the main topic of discussion and avoid
unnecessary “detours” into other topics.
The quality of focus group and interview data was also affected by the fact that
most of the consumer focus group and interview participants had significant thought
disorders. Though the majority of participants were able to stay on task and contribute to
the data collection process in a clear and organized fashion, there were times when
participants’ thought disorders affected the coherence of their speech.

Saavedra, Cubero

& Crawford (2009) offer interesting insights into the coherence of the narratives of
individuals with schizophrenia, and they point out that despite significant thought
disorder, many individuals with schizophrenia are able to tell a narrative of their life
experiences. By transcribing focus groups and interviews shortly after conducting them,
and by keeping groups small, the investigator was able to decipher participants’
narratives and understand their contribution to the process.
Furthermore, the quantitative findings were limited by the small number of
benchmark Part D plans available to Missouri beneficiaries in 2009. With only six plans
to compare, the ability to draw conclusions about benchmark plans is constrained. The
limited variability in the plan attributes also affected the ability to analyze these data in a
meaningful way.
Implications for Social Work Research
The finding in this study that most beneficiaries are quite satisfied with their Part
D benefits is counterintuitive, when compared with the predictions of Medicare advocacy
groups (MRC, 2005) and the observations of psychiatrists who have been surveyed about
Part D (West et al., 2007; West et al., 2009). Therefore, there needs to be further study of
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dually-eligible Medicare beneficiaries with mental illness, to examine more thoroughly
the reasons for their high level of satisfaction with Part D. It would be useful to
undertake a broader survey of beneficiaries with mental illness, so that broader trends in
Part D could be examined. The findings of this study are limited by their geographic
specificity; use of a Medicare beneficiary survey to collect more representative data on
mentally ill beneficiaries’ satisfaction would provide valuable insights.
In addition, research needs to be conducted to determine whether dually-eligible
older adult beneficiaries with mental illness have different needs than younger Medicare
beneficiaries disabled by mental illness. The sample in this particular study included
mostly beneficiaries under age 65; older adult beneficiaries with mood disorders or
schizophrenia may have different needs, especially related to medical co-morbidity.
Studies of older adult Medicare beneficiaries have not attempted to disentangle the
experiences of beneficiaries with mental illnesses from the larger population of elderly
Medicare participants.
Another implication for social work research is that the role of social workers in
assisting mentally ill beneficiaries with their Part D benefits needs to be more adequately
studied. The Mental Health Part D Web site discusses the importance of community case
managers, residential and inpatient staff, and assertive community treatment team
members in accessing and utilizing Part D benefits for adults with mental illness, but the
exact roles and tasks undertaken by these professionals, many of whom are social
workers, have gone unstudied until now. This study found that St. Louis-area
community support workers and case managers were very active in a variety of tasks
related to accessing medication, medication adherence, and use of insurance programs.
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Further study of social workers’ roles regarding access to Part D, as well as the
pharmacological management of mental illness, would be useful.
Research also needs to be conducted to determine how much social workers and
other community-based case managers know about the Medicare Part D benefit. Ferri
and Cox (2009) discovered that social work students were not very knowledgeable
regarding the Medicare prescription drug program. It would be useful to survey social
workers and case managers in community settings to assess their knowledge and
understand where gaps in program understanding may be occurring. This would greatly
enhance efforts to educate community-based mental health professionals about the use of
the Part D program.
In addition, patient-centered care principles should be used more frequently in
social work research. Though “client-centered care” is occasionally mentioned in the
social work literature (Jindani & Murdock, 2009), the principles of patient-centered care
as they are described in the health care literature are relevant to social workers. Patientcentered care is applicable to many typical social work roles, such as advocacy, care
coordination, and rehabilitation services. Patient-centered care can be used not only in
health services and health policy research, but also as a tool for assessing social service
and mental health programs dominated by social work professionals. Leplege et al.
(2007) have mentioned that non-medical mental health professionals have shied away
from the term “patient-centered care.” Nonetheless, social work and psychiatric
rehabilitation professionals should embrace the principles underlying the concept of
patient-centered care and use them to evaluate the quality of community mental health
services.
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Implications for Health Care Policy
It appears that Medicare Part D is here to stay (Kaiser Family Foundation, 2010).
The new health reform law includes a few provisions related to Part D, the most
important of which is probably the effort to close the “doughnut hole” coverage gap over
the next several years. This will likely have little impact on dually-eligible beneficiaries,
however, as they already have low-income subsidy assistance in the coverage gap. For
beneficiaries with slightly higher incomes, the closing of the “doughnut hole” will be
extremely helpful, as it will reduce out-of-pocket costs for these individuals.
The newly-initiated efforts within the Centers for Medicare and Medicaid
Services to coordinate Medicare and Medicaid benefits have the potential to improve
access to coverage for many dually-eligible beneficiaries (Kaiser Family Foundation,
2010). Coordination of benefits provided by the Medicare and Medicaid program could
lead to better coverage and fewer gaps such as the current gap in dental care for lowincome beneficiaries. It could also help ensure that at least some drugs not covered by
Medicare Part D will be paid for by the Medicaid program. The Centers for Medicare
and Medicaid Services do need to take constructive action to ensure better coordination
between the Medicare and Medicaid programs. At present, the coordination of these
programs is largely left in the hands of community professionals and helpers; better
organization on the system level would take a large burden off of case managers and
pharmacists.
The Centers for Medicare and Medicaid Services also need to take action to
ensure better information and communication from Part D plans to stakeholders.
Advertisements for Part D plans and Medicare Advantage plans need to be monitored and
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clearly identified as advertising, so that beneficiaries do not switch plans or dis-enroll
from a plan because they believe they are “required” to do so. Too much of the current
advertising appears in a form that is interpreted by beneficiaries as a directive from the
Medicare program.
Furthermore, the level of health literacy of beneficiaries needs to be taken into
account in Medicare communications. The Centers for Medicare and Medicaid Services
need to recognize that terms such as “catastrophic” and “benchmark” may confuse
beneficiaries. Reading levels of Medicare materials must be brought down, and at the
same time, CMS needs to undertake community-level efforts to improve the health
literacy of lower-income Medicare beneficiaries.
Implications for Social Work Policy and Practice
Clients need help to use this benefit. The nature of the paperwork and the
language used by benefit plans are such that the average citizen has a hard time
understanding them (Cummings, Rice, & Hanoch, 2009). In the stakeholder focus
groups, not only beneficiaries but also community support workers expressed their
difficulties in comprehending the Part D paperwork. In addition, low-income
beneficiaries did not have extensive computer access, so Web-based tools and
information, on which community support workers were reliant for knowledge of the Part
D benefit, were not available or particularly helpful to beneficiaries. Beneficiaries with
disabilities are likely to face similar problems as older adults experience in using the
Medicare Web site, so resources need to be more accessible (Czaja, Sharit, & Nair,
2008). Research on computer use among the elderly has confirmed that those with
disabilities and those with lower incomes have less access to computers (Wright & Hill,
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2009). For adequate information, communication, and education to be provided to
beneficiaries and their helpers, print resources need to be available to beneficiaries.
Printed materials should be distributed through community mental health agencies, in
addition to being mailed to beneficiaries. Furthermore, greater computer/Internet access
needs to be provided to mental health consumers in clubhouse settings.
Web-based resources should be more broadly promoted among community
support workers and nurse-case managers, so that they can use these tools to help their
clients obtain what they need from the Part D program. There are many Web sites with
valuable information about accessing the Part D benefit, not only the official Medicare
Web site, but also a number of informational Web sites sponsored by non-profit
organizations and advocacy groups. These resources need to be more widely publicized
so that community-based mental health professionals can more easily take advantage of
them.
Furthermore, there needs to be a mechanism for paying for community-based
service coordination for dually-eligible beneficiaries with mental or cognitive conditions.
Part D provides a mechanism for pharmacists to be reimbursed for medication therapy
management (MTM) services to Medicare beneficiaries with chronic conditions, but
many pharmacists do not take advantage of this source of payment. This may be in part
because they view MTM as a way for the Medicare program to contain costs, rather than
as a mechanism for effective and compassionate service provision to medically
vulnerable beneficiaries. In addition, there is no provision for social workers or other
community providers to be paid for the work that they do in coordinating prescription
drug benefits (Kravitz & Chang, 2005). It is not clear whether Medicare Part D should
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pay for this service, or whether funding should come from another federal or state source.
Currently, the services of community support workers at mental health agencies are
largely financed through Medicaid. The examination of patient-centered care principles
in the Part D program illustrates the tremendous importance of care continuity and
emotional support. Community-based service coordination should be reimbursed
(National Health Council, 2009; Thorpe et al., 2010).
The services of State Health Insurance Assistance (SHIP) programs, at least in the
state of Missouri, need to be more broadly promoted. Stakeholders, be they beneficiaries
or their helpers, do not know where to go to get help related to Part D. Not a single focus
group or interview participant mentioned Missouri CLAIM (Community Leaders
Assisting the Insured of Missouri; Missouri’s SHIP program) as a source of information
about Part D. Collaboration between the CLAIM program and community mental health
agencies, similar to the collaborations between the CLAIM program and agencies that
serve the elderly and people with physical disabilities should be encouraged. CLAIM
may even be able to train volunteer counselors from mental health agencies, as they have
done with volunteers from agencies for the aging. This would lead to greater education
and empowerment—key aspects of patient-centered care.
“Smart” methods of assigning benchmark plans to low-income beneficiaries must
be used, so that beneficiaries and their helpers do not have to spend a great deal of time
and energy determining whether the prescription drug plan to which the beneficiary has
been randomly assigned is the best fit for him/her or not (Summer et al., 2008). The
switching process should not be as burdensome to beneficiaries as it is under the current
system of re-assigning prescription drug plans. This would contribute greatly to the
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patient-centeredness of the Part D program, by promoting coordination of care as well as
continuity and secure transitions (Neuman & Cubanski, 2009).
Implications for Social Work Education
It is clear from this study that generalist social workers, those who are likely to be
in case management positions helping adults with mental illness, need a thorough
knowledge of Medicare. It needs to be stressed in bachelor’s- and master’s-level social
policy courses that Medicare is not just the territory of the elderly, but an important
resource to many men and women with permanent disabilities. Education of generalist
social workers also needs to emphasize the fact that low-income Medicare beneficiaries
are more likely to have serious mental illness than higher-income beneficiaries. Current
research indicates that social work students do not know very much about Medicare Part
D; this situation needs to be addressed in social work curricula (Ferri & Cox, 2009).
Another implication for social work education is that there is a need, more than
ever, for social workers to be able to communicate across health care disciplines. Case
managers are often in the position of having to communicate about clients’ medication
needs with nurses, pharmacists, and physicians, and the ability to “speak a common
language” affects the case manager’s ability to meet the client’s needs.
The important role of social workers in medication access and adherence has not
been stressed enough in social work education or in the professional literature. Case
managers not only assist people with benefits information and statements from their
prescription drug plans; they are also helping people to obtain their medications and
filling medicine planners. Graduate social workers in particular need knowledge of
psychopharmacology and health care policy to be effective in their community roles.

136

Further examination is needed of the roles social workers play in medication adherence in
the community. As Pedan et al. (2009) have stated, health care providers have a
responsibility to raise awareness among their clients regarding their prescription drug
coverage and costs; educating social workers for this role is essential.
The knowledge generated in this study will not only advance our understanding of
the Medicare prescription drug benefit as it has been implemented thus far, but will also
help researchers and policy-makers to understand how Medicare policy can be reformed
to better serve the needs of adults with serious mental illness. A better knowledge of
stakeholders’ priorities and an accurate understanding of the patient-centeredness of the
various Part D plans will enable policy-makers to undertake legislative and regulatory
changes that can make this program work better for some of its most vulnerable
beneficiaries.
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